Int64Index: 74 entries, 61 to 4596 memory usage: 4.6+ KB
count null dtype
column
WkD_disease 74 non-null object
WkD_diseaseLabel 74 non-null object
WP_en_article 74 non-null object
class 74 non-null object
importance 74 non-null object
taskForces 74 non-null object
cochrane_reviews_html 74 non-null object

Table Guide:

Grouping:

In cases, where there are multiple version of a Cochrane review, they are grouped toghther (showing the same background color) ,and are listed chronologically,latest version first.

Color Codes:

  1. Green: up-to-date and CITED

  2. Red: up-to-date and NOT CITED

  3. Orange: out-of-date and CITED

  4. Grey: out-of-date and NOT CITED

Results Table contains 74 rows

WkD_disease WkD_diseaseLabel WP_en_article class importance taskForces cochrane_reviews_html
index
4596 Q41571 epilepsy Epilepsy GA 1-Top

Neurology

Psychiatry
  1. Acupuncture for epilepsy. PMID: 24801225 [CITED] [LATEST Version]
  2. Acupuncture for epilepsy. PMID: 18843676 [NOT CITED] [OLD Version]
  3. Acupuncture for epilepsy. PMID: 16625622 [NOT CITED] [OLD Version]
  4. Antidepressants for people with epilepsy and depression. PMID: 25464360 [NOT CITED] [LATEST Version]
  5. Antiepileptic drug monotherapy for epilepsy: a network meta-analysis of individual participant data. PMID: 29243813 [NOT CITED] [LATEST Version]
  6. Antiepileptic drug monotherapy for epilepsy: a network meta-analysis of individual participant data. PMID: 28661008 [NOT CITED] [OLD Version]
  7. Antiepileptic drugs for the treatment of infants with severe myoclonic epilepsy. PMID: 28521067 [NOT CITED] [LATEST Version]
  8. Antiepileptic drugs for the treatment of infants with severe myoclonic epilepsy. PMID: 26482210 [NOT CITED] [OLD Version]
  9. Antiepileptic drugs for the treatment of severe myoclonic epilepsy in infancy. PMID: 24254932 [NOT CITED] [LATEST Version]
  10. Brivaracetam add-on therapy for drug-resistant epilepsy. PMID: 30920649 [NOT CITED] [LATEST Version]
  11. Calcium antagonists as an add-on therapy for drug-resistant epilepsy. PMID: 23543516 [NOT CITED] [LATEST Version]
  12. Calcium antagonists as an add-on therapy for drug-resistant epilepsy. PMID: 11687158 [NOT CITED] [OLD Version]
  13. Cannabinoids for epilepsy. PMID: 24595491 [NOT CITED] [LATEST Version]
  14. Cannabinoids for epilepsy. PMID: 22696383 [NOT CITED] [OLD Version]
  15. Carbamazepine versus phenobarbitone monotherapy for epilepsy. PMID: 12535420 [NOT CITED] [LATEST Version]
  16. Carbamazepine versus phenobarbitone monotherapy for epilepsy: an individual participant data review. PMID: 30353945 [NOT CITED] [LATEST Version]
  17. Carbamazepine versus phenobarbitone monotherapy for epilepsy: an individual participant data review. PMID: 27976799 [NOT CITED] [OLD Version]
  18. Carbamazepine versus phenobarbitone monotherapy for epilepsy: an individual participant data review. PMID: 26204241 [NOT CITED] [OLD Version]
  19. Carbamazepine versus phenytoin monotherapy for epilepsy. PMID: 12076427 [NOT CITED] [LATEST Version]
  20. Carbamazepine versus phenytoin monotherapy for epilepsy: an individual participant data review. PMID: 31318037 [CITED] [LATEST Version]
  21. Carbamazepine versus phenytoin monotherapy for epilepsy: an individual participant data review. PMID: 28240353 [NOT CITED] [OLD Version]
  22. Carbamazepine versus phenytoin monotherapy for epilepsy: an individual participant data review. PMID: 26275105 [NOT CITED] [OLD Version]
  23. Carbamazepine versus valproate monotherapy for epilepsy. PMID: 10908558 [NOT CITED] [LATEST Version]
  24. Care delivery and self management strategies for adults with epilepsy. PMID: 26842929 [NOT CITED] [LATEST Version]
  25. Care delivery and self management strategies for children with epilepsy. PMID: 26695883 [NOT CITED] [LATEST Version]
  26. Care delivery and self-management strategies for adults with epilepsy. PMID: 18254097 [NOT CITED] [LATEST Version]
  27. Care delivery and self-management strategies for children with epilepsy. PMID: 29493780 [NOT CITED] [LATEST Version]
  28. Care delivery and self-management strategies for children with epilepsy. PMID: 21154365 [NOT CITED] [OLD Version]
  29. Clobazam as an add-on in the management of refractory epilepsy. PMID: 18425899 [NOT CITED] [LATEST Version]
  30. Clonazepam add-on therapy for refractory epilepsy in adults and children. PMID: 29717488 [NOT CITED] [LATEST Version]
  31. Common antiepileptic drugs in pregnancy in women with epilepsy. PMID: 15266543 [NOT CITED] [LATEST Version]
  32. Comparison of antiepileptic drugs, no treatment, or placebo for children with benign epilepsy with centro temporal spikes. PMID: 25190506 [NOT CITED] [LATEST Version]
  33. Corticosteroids including ACTH for childhood epilepsy other than epileptic spasms. PMID: 26086765 [NOT CITED] [LATEST Version]
  34. Corticosteroids including ACTH for childhood epilepsy other than epileptic spasms. PMID: 17253546 [NOT CITED] [OLD Version]
  35. Deep brain and cortical stimulation for epilepsy. PMID: 28718878 [NOT CITED] [LATEST Version]
  36. Deep brain and cortical stimulation for epilepsy. PMID: 24937707 [NOT CITED] [OLD Version]
  37. Early versus late antiepileptic drug withdrawal for people with epilepsy in remission. PMID: 25922863 [NOT CITED] [LATEST Version]
  38. Early versus late antiepileptic drug withdrawal for people with epilepsy in remission. PMID: 11687000 [NOT CITED] [OLD Version]
  39. Epilepsy clinics versus general neurology or medical clinics. PMID: 11279739 [NOT CITED] [LATEST Version]
  40. Eslicarbazepine acetate add-on for drug-resistant partial epilepsy. PMID: 29067682 [NOT CITED] [LATEST Version]
  41. Eslicarbazepine acetate add-on for drug-resistant partial epilepsy. PMID: 22161441 [NOT CITED] [OLD Version]
  42. Felbamate add-on therapy for drug-resistant focal epilepsy. PMID: 31425617 [NOT CITED] [LATEST Version]
  43. Felbamate as an add-on therapy for refractory epilepsy. PMID: 25036694 [NOT CITED] [LATEST Version]
  44. Felbamate as an add-on therapy for refractory epilepsy. PMID: 21249704 [NOT CITED] [OLD Version]
  45. Felbamate as an add-on therapy for refractory partial epilepsy. PMID: 28718506 [NOT CITED] [LATEST Version]
  46. Gabapentin add-on for drug-resistant partial epilepsy. PMID: 23888424 [NOT CITED] [LATEST Version]
  47. Gabapentin add-on for drug-resistant partial epilepsy. PMID: 10908495 [NOT CITED] [OLD Version]
  48. Gabapentin add-on treatment for drug-resistant focal epilepsy. PMID: 30357813 [NOT CITED] [LATEST Version]
  49. Gabapentin for drug-resistant partial epilepsy. PMID: 10796785 [NOT CITED] [LATEST Version]
  50. Immediate-release versus controlled-release carbamazepine in the treatment of epilepsy. PMID: 27933615 [CITED] [LATEST Version]
  51. Immediate-release versus controlled-release carbamazepine in the treatment of epilepsy. PMID: 25470302 [NOT CITED] [OLD Version]
  52. Immediate-release versus controlled-release carbamazepine in the treatment of epilepsy. PMID: 24488654 [NOT CITED] [OLD Version]
  53. Immediate-release versus controlled-release carbamazepine in the treatment of epilepsy. PMID: 20091617 [NOT CITED] [OLD Version]
  54. Immunomodulatory interventions for focal epilepsy syndromes. PMID: 23803963 [CITED] [LATEST Version]
  55. Interventions for psychotic symptoms concomitant with epilepsy. PMID: 26690687 [NOT CITED] [LATEST Version]
  56. Interventions for psychotic symptoms concomitant with epilepsy. PMID: 18843704 [NOT CITED] [OLD Version]
  57. Intravenous immunoglobulins for epilepsy. PMID: 28675262 [NOT CITED] [LATEST Version]
  58. Intravenous immunoglobulins for epilepsy. PMID: 21249713 [NOT CITED] [OLD Version]
  59. Ketogenic diet and other dietary treatments for epilepsy. PMID: 26859528 [CITED] [LATEST Version]
  60. Ketogenic diet and other dietary treatments for epilepsy. PMID: 22419282 [NOT CITED] [OLD Version]
  61. Ketogenic diet for epilepsy. PMID: 12917915 [NOT CITED] [LATEST Version]
  62. Ketogenic diets for drug-resistant epilepsy. PMID: 30403286 [CITED] [LATEST Version]
  63. Lacosamide add-on therapy for partial epilepsy. PMID: 26077821 [NOT CITED] [LATEST Version]
  64. Lamotrigine add-on for drug-resistant partial epilepsy. PMID: 27329345 [NOT CITED] [LATEST Version]
  65. Lamotrigine add-on for drug-resistant partial epilepsy. PMID: 11687001 [NOT CITED] [OLD Version]
  66. Lamotrigine add-on for drug-resistant partial epilepsy. PMID: 10908514 [NOT CITED] [OLD Version]
  67. Lamotrigine versus carbamazepine monotherapy for epilepsy. PMID: 16437428 [NOT CITED] [LATEST Version]
  68. Lamotrigine versus carbamazepine monotherapy for epilepsy: an individual participant data review. PMID: 29952431 [NOT CITED] [LATEST Version]
  69. Lamotrigine versus carbamazepine monotherapy for epilepsy: an individual participant data review. PMID: 27841445 [NOT CITED] [OLD Version]
  70. Levetiracetam add-on for drug-resistant focal epilepsy: an updated Cochrane Review. PMID: 22972056 [NOT CITED] [LATEST Version]
  71. Levetiracetam add-on for drug-resistant localization related (partial) epilepsy. PMID: 11279737 [NOT CITED] [LATEST Version]
  72. Losigamone add-on therapy for focal epilepsy. PMID: 29355908 [NOT CITED] [LATEST Version]
  73. Losigamone add-on therapy for partial epilepsy. PMID: 26661741 [NOT CITED] [LATEST Version]
  74. Losigamone add-on therapy for partial epilepsy. PMID: 22696384 [NOT CITED] [OLD Version]
  75. Melatonin as add-on treatment for epilepsy. PMID: 27513702 [CITED] [LATEST Version]
  76. Melatonin as add-on treatment for epilepsy. PMID: 26986179 [NOT CITED] [OLD Version]
  77. Melatonin as add-on treatment for epilepsy. PMID: 22696363 [NOT CITED] [OLD Version]
  78. Monotherapy treatment of epilepsy in pregnancy: congenital malformation outcomes in the child. PMID: 27819746 [CITED] [LATEST Version]
  79. Neuropsychological and psychological interventions for people with newly diagnosed epilepsy. PMID: 26198593 [NOT CITED] [LATEST Version]
  80. Non-pharmacological interventions for epilepsy in people with intellectual disabilities. PMID: 17943860 [NOT CITED] [LATEST Version]
  81. Non-pharmacological interventions for people with epilepsy and intellectual disabilities. PMID: 26355236 [NOT CITED] [LATEST Version]
  82. Oxcarbazepine add-on for drug-resistant partial epilepsy. PMID: 10908522 [NOT CITED] [LATEST Version]
  83. Oxcarbazepine versus phenytoin monotherapy for epilepsy. PMID: 23728645 [NOT CITED] [LATEST Version]
  84. Oxcarbazepine versus phenytoin monotherapy for epilepsy. PMID: 16625587 [NOT CITED] [OLD Version]
  85. Oxcarbazepine versus phenytoin monotherapy for epilepsy: an individual participant data review. PMID: 30350354 [NOT CITED] [LATEST Version]
  86. Pharmacological interventions for epilepsy in people with intellectual disabilities. PMID: 26333428 [NOT CITED] [LATEST Version]
  87. Pharmacological interventions for epilepsy in people with intellectual disabilities. PMID: 17636795 [NOT CITED] [OLD Version]
  88. Pharmacological treatments for preventing epilepsy following traumatic head injury. PMID: 26259048 [NOT CITED] [LATEST Version]
  89. Phenobarbitone versus phenytoin monotherapy for epilepsy: an individual participant data review. PMID: 31425629 [NOT CITED] [LATEST Version]
  90. Polyunsaturated fatty acid supplementation for drug-resistant epilepsy. PMID: 27536971 [NOT CITED] [LATEST Version]
  91. Preconception counselling for women with epilepsy to reduce adverse pregnancy outcome. PMID: 18646164 [NOT CITED] [LATEST Version]
  92. Pregabalin add-on for drug-resistant focal epilepsy. PMID: 31287157 [NOT CITED] [LATEST Version]
  93. Pregabalin add-on for drug-resistant partial epilepsy. PMID: 24623260 [NOT CITED] [LATEST Version]
  94. Pregabalin add-on for drug-resistant partial epilepsy. PMID: 18254084 [NOT CITED] [OLD Version]
  95. Pregabalin monotherapy for epilepsy. PMID: 23076957 [NOT CITED] [LATEST Version]
  96. Psychological treatments for epilepsy. PMID: 18646083 [NOT CITED] [LATEST Version]
  97. Psychological treatments for epilepsy. PMID: 16235293 [NOT CITED] [OLD Version]
  98. Psychological treatments for epilepsy. PMID: 14583944 [NOT CITED] [OLD Version]
  99. Psychological treatments for epilepsy. PMID: 11687134 [NOT CITED] [OLD Version]
  100. Psychological treatments for people with epilepsy. PMID: 29078005 [CITED] [LATEST Version]
  101. Remacemide for drug-resistant localization related epilepsy. PMID: 12519561 [NOT CITED] [LATEST Version]
  102. Rufinamide add-on therapy for refractory epilepsy. PMID: 29691835 [NOT CITED] [LATEST Version]
  103. Self-management education for adults with epilepsy. PMID: 17443553 [NOT CITED] [LATEST Version]
  104. Self-management education for children with epilepsy. PMID: 17443554 [NOT CITED] [LATEST Version]
  105. Sodium valproate versus phenytoin monotherapy for epilepsy: an individual participant data review. PMID: 30091458 [CITED] [LATEST Version]
  106. Specialist epilepsy nurses for treating epilepsy. PMID: 11687130 [NOT CITED] [LATEST Version]
  107. Specialist epilepsy nurses for treating epilepsy. PMID: 11279738 [NOT CITED] [OLD Version]
  108. Stiripentol add-on therapy for focal refractory epilepsy. PMID: 29747241 [NOT CITED] [LATEST Version]
  109. Stiripentol for focal refractory epilepsy. PMID: 26488459 [NOT CITED] [LATEST Version]
  110. Stiripentol for focal refractory epilepsy. PMID: 24488598 [NOT CITED] [OLD Version]
  111. Strategies for improving adherence to antiepileptic drug treatment in patients with epilepsy. PMID: 21249705 [NOT CITED] [LATEST Version]
  112. Strategies for improving adherence to antiepileptic drug treatment in people with epilepsy. PMID: 28157274 [NOT CITED] [LATEST Version]
  113. Subpial transection surgery for epilepsy. PMID: 30383287 [NOT CITED] [LATEST Version]
  114. Subpial transection surgery for epilepsy. PMID: 26633802 [NOT CITED] [OLD Version]
  115. Subpial transection surgery for epilepsy. PMID: 23963657 [NOT CITED] [OLD Version]
  116. Sulthiame add-on therapy for epilepsy. PMID: 31453633 [NOT CITED] [LATEST Version]
  117. Sulthiame add-on therapy for epilepsy. PMID: 26510094 [NOT CITED] [OLD Version]
  118. Sulthiame add-on therapy for epilepsy. PMID: 23543577 [NOT CITED] [OLD Version]
  119. Sulthiame monotherapy for epilepsy. PMID: 24609897 [NOT CITED] [LATEST Version]
  120. Surgery for epilepsy. PMID: 31237346 [NOT CITED] [LATEST Version]
  121. Surgery for epilepsy. PMID: 26130264 [NOT CITED] [OLD Version]
  122. The role of high-frequency oscillations in epilepsy surgery planning. PMID: 28981957 [NOT CITED] [LATEST Version]
  123. The role of high-frequency oscillations in epilepsy surgery planning. PMID: 24431136 [NOT CITED] [OLD Version]
  124. Therapeutic monitoring of antiepileptic drugs for epilepsy. PMID: 17253477 [NOT CITED] [LATEST Version]
  125. Tiagabine add-on for drug-resistant partial epilepsy. PMID: 24500879 [NOT CITED] [LATEST Version]
  126. Tiagabine add-on for drug-resistant partial epilepsy. PMID: 22592677 [NOT CITED] [OLD Version]
  127. Tiagabine add-on for drug-resistant partial epilepsy. PMID: 12137637 [NOT CITED] [OLD Version]
  128. Topiramate add-on for drug-resistant partial epilepsy. PMID: 24570033 [NOT CITED] [LATEST Version]
  129. Topiramate add-on for drug-resistant partial epilepsy. PMID: 18646072 [NOT CITED] [OLD Version]
  130. Topiramate add-on for drug-resistant partial epilepsy. PMID: 12137625 [NOT CITED] [OLD Version]
  131. Topiramate for drug-resistant partial epilepsy. PMID: 10796787 [NOT CITED] [LATEST Version]
  132. Topiramate for juvenile myoclonic epilepsy. PMID: 30687937 [NOT CITED] [LATEST Version]
  133. Topiramate monotherapy for juvenile myoclonic epilepsy. PMID: 28434203 [NOT CITED] [LATEST Version]
  134. Topiramate monotherapy for juvenile myoclonic epilepsy. PMID: 26695884 [NOT CITED] [OLD Version]
  135. Topiramate versus carbamazepine monotherapy for epilepsy: an individual participant data review. PMID: 31233229 [NOT CITED] [LATEST Version]
  136. Topiramate versus carbamazepine monotherapy for epilepsy: an individual participant data review. PMID: 27922722 [NOT CITED] [OLD Version]
  137. Traditional Chinese medicine for epilepsy. PMID: 19588391 [NOT CITED] [LATEST Version]
  138. Transcranial magnetic stimulation for the treatment of epilepsy. PMID: 27513825 [NOT CITED] [LATEST Version]
  139. Treatment for epilepsy in pregnancy: neurodevelopmental outcomes in the child. PMID: 25354543 [NOT CITED] [LATEST Version]
  140. Treatment of epilepsy for people with Alzheimer's disease. PMID: 30570742 [NOT CITED] [LATEST Version]
  141. Treatment of epilepsy for people with Alzheimer's disease. PMID: 27805721 [NOT CITED] [OLD Version]
  142. Treatments for the prevention of Sudden Unexpected Death in Epilepsy (SUDEP). PMID: 27434597 [NOT CITED] [LATEST Version]
  143. Vigabatrin for refractory partial epilepsy. PMID: 23440814 [NOT CITED] [LATEST Version]
  144. Vigabatrin for refractory partial epilepsy. PMID: 18646179 [NOT CITED] [OLD Version]
  145. Vigabatrin versus carbamazepine monotherapy for epilepsy. PMID: 26580100 [NOT CITED] [LATEST Version]
  146. Vigabatrin versus carbamazepine monotherapy for epilepsy. PMID: 22258989 [NOT CITED] [OLD Version]
  147. Vitamins for epilepsy. PMID: 15846704 [CITED] [LATEST Version]
  148. Yoga for epilepsy. PMID: 28982217 [CITED] [LATEST Version]
  149. Yoga for epilepsy. PMID: 25934967 [NOT CITED] [OLD Version]
  150. Yoga for epilepsy. PMID: 10796803 [NOT CITED] [OLD Version]
  151. Yoga for epilepsy. PMID: 10908505 [NOT CITED] [OLD Version]
  152. Zonisamide add-on for drug-resistant partial epilepsy. PMID: 24353187 [NOT CITED] [LATEST Version]
  153. Zonisamide add-on for drug-resistant partial epilepsy. PMID: 16235282 [NOT CITED] [OLD Version]
  154. Zonisamide add-on for drug-resistant partial epilepsy. PMID: 12076409 [NOT CITED] [OLD Version]
  155. Zonisamide add-on therapy for focal epilepsy. PMID: 30335200 [NOT CITED] [LATEST Version]
  156. Zonisamide for drug-resistant partial epilepsy. PMID: 10796786 [NOT CITED] [LATEST Version]
4408 Q12135 mental disorder Mental disorder C 1-Top

Psychiatry
  1. Aripiprazole alone or in combination for acute mania. PMID: 24346956 [NOT CITED] [LATEST Version]
  2. Assertive community treatment for people with severe mental disorders. PMID: 10796415 [NOT CITED] [LATEST Version]
  3. Case management for people with severe mental disorders. PMID: 10796288 [NOT CITED] [LATEST Version]
  4. Chlorpromazine versus clotiapine for schizophrenia. PMID: 28387925 [NOT CITED] [LATEST Version]
  5. Chlorpromazine versus piperacetazine for schizophrenia. PMID: 30378678 [NOT CITED] [LATEST Version]
  6. Consultation liaison in primary care for people with mental disorders. PMID: 26384252 [NOT CITED] [LATEST Version]
  7. Different regimens of intravenous sedatives or hypnotics for electroconvulsive therapy (ECT) in adult patients with depression. PMID: 24723301 [NOT CITED] [LATEST Version]
  8. Electroconvulsive therapy for schizophrenia. PMID: 15846598 [NOT CITED] [LATEST Version]
  9. Electroconvulsive therapy for schizophrenia. PMID: 12076380 [NOT CITED] [OLD Version]
  10. Electroconvulsive therapy for schizophrenia. PMID: 10796292 [NOT CITED] [OLD Version]
  11. Electroconvulsive therapy for the depressed elderly. PMID: 12804479 [NOT CITED] [LATEST Version]
  12. Interventions for preventing delirium in hospitalised non-ICU patients. PMID: 26967259 [NOT CITED] [LATEST Version]
  13. Interventions for preventing delirium in hospitalised patients. PMID: 17443600 [NOT CITED] [LATEST Version]
  14. Interventions for preventing delirium in older people in institutional long-term care. PMID: 31012953 [NOT CITED] [LATEST Version]
  15. Nidotherapy for people with schizophrenia. PMID: 23543583 [NOT CITED] [LATEST Version]
  16. Supported employment for adults with severe mental illness. PMID: 24030739 [NOT CITED] [LATEST Version]
  17. Supported housing for people with severe mental disorders. PMID: 17054130 [NOT CITED] [LATEST Version]
  18. Supported housing for people with severe mental disorders. PMID: 12519544 [NOT CITED] [OLD Version]
  19. Supported housing for people with severe mental disorders. PMID: 12076398 [NOT CITED] [OLD Version]
  20. Vortioxetine for depression in adults. PMID: 28677828 [NOT CITED] [LATEST Version]
123 Q83030 dementia Dementia B 1-Top

Neurology

Psychiatry
  1. (11)C-PIB-PET for the early diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI). PMID: 25052054 [NOT CITED] [LATEST Version]
  2. 18F PET with florbetaben for the early diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI). PMID: 29164600 [NOT CITED] [LATEST Version]
  3. 18F PET with florbetapir for the early diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI). PMID: 29164603 [NOT CITED] [LATEST Version]
  4. 18F PET with flutemetamol for the early diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI). PMID: 29164602 [NOT CITED] [LATEST Version]
  5. Acetyl-L-carnitine for dementia. PMID: 12804452 [NOT CITED] [LATEST Version]
  6. Acupuncture for vascular dementia. PMID: 17443563 [NOT CITED] [LATEST Version]
  7. AD-8 for detection of dementia across a variety of healthcare settings. PMID: 30828783 [NOT CITED] [LATEST Version]
  8. Adjunctive therapies for AIDS dementia complex. PMID: 18646159 [NOT CITED] [LATEST Version]
  9. Almitrine-Raubasine combination for dementia. PMID: 21412915 [NOT CITED] [LATEST Version]
  10. Alpha lipoic acid for dementia. PMID: 14974062 [NOT CITED] [LATEST Version]
  11. Antidepressants for agitation and psychosis in dementia. PMID: 21328305 [CITED] [LATEST Version]
  12. Antidepressants for treating depression in dementia. PMID: 30168578 [CITED] [LATEST Version]
  13. Antidepressants for treating depression in dementia. PMID: 12519625 [NOT CITED] [OLD Version]
  14. Aroma therapy for dementia. PMID: 12917949 [NOT CITED] [LATEST Version]
  15. Aromatherapy for dementia. PMID: 24569873 [CITED] [LATEST Version]
  16. Art therapy for people with dementia. PMID: 30215847 [NOT CITED] [LATEST Version]
  17. Aspirin for vascular dementia. PMID: 11034710 [NOT CITED] [LATEST Version]
  18. Aspirin for vascular dementia. PMID: 10796639 [NOT CITED] [OLD Version]
  19. Assistive technology for memory support in dementia. PMID: 28602027 [NOT CITED] [LATEST Version]
  20. Blood pressure lowering in patients without prior cerebrovascular disease for prevention of cognitive impairment and dementia. PMID: 19821318 [NOT CITED] [LATEST Version]
  21. Blood pressure-lowering treatment for preventing recurrent stroke, major vascular events, and dementia in patients with a history of stroke or transient ischaemic attack. PMID: 30024023 [NOT CITED] [LATEST Version]
  22. Cannabinoids for the treatment of dementia. PMID: 19370677 [NOT CITED] [LATEST Version]
  23. Case management approaches to home support for people with dementia. PMID: 25560977 [NOT CITED] [LATEST Version]
  24. Cerebrolysin for vascular dementia. PMID: 23440834 [NOT CITED] [LATEST Version]
  25. Cholinesterase inhibitors for dementia with Lewy bodies, Parkinson's disease dementia and cognitive impairment in Parkinson's disease. PMID: 22419314 [CITED] [LATEST Version]
  26. Cholinesterase inhibitors for dementia with Lewy bodies. PMID: 12917981 [NOT CITED] [LATEST Version]
  27. Cholinesterase inhibitors for Parkinson's disease dementia. PMID: 16437494 [NOT CITED] [LATEST Version]
  28. Cognitive reframing for carers of people with dementia. PMID: 22071821 [CITED] [LATEST Version]
  29. Cognitive rehabilitation and cognitive training for early-stage Alzheimer's disease and vascular dementia. PMID: 14583963 [NOT CITED] [LATEST Version]
  30. Cognitive stimulation to improve cognitive functioning in people with dementia. PMID: 22336813 [CITED] [LATEST Version]
  31. Cognitive training and cognitive rehabilitation for mild to moderate Alzheimer's disease and vascular dementia. PMID: 23740535 [NOT CITED] [LATEST Version]
  32. Cognitive training for people with mild to moderate dementia. PMID: 30909318 [NOT CITED] [LATEST Version]
  33. Computerised cognitive training for preventing dementia in people with mild cognitive impairment. PMID: 30864747 [NOT CITED] [LATEST Version]
  34. CSF tau and the CSF tau/ABeta ratio for the diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI). PMID: 28328043 [NOT CITED] [LATEST Version]
  35. Dance movement therapy for dementia. PMID: 28155990 [NOT CITED] [LATEST Version]
  36. Donepezil for dementia due to Alzheimer's disease. PMID: 29923184 [NOT CITED] [LATEST Version]
  37. Donepezil for dementia due to Alzheimer's disease. PMID: 16437430 [NOT CITED] [OLD Version]
  38. Donepezil for dementia due to Alzheimer's disease. PMID: 12917900 [NOT CITED] [OLD Version]
  39. Donepezil for dementia in people with Down syndrome. PMID: 19160328 [NOT CITED] [LATEST Version]
  40. Dopamine transporter imaging for the diagnosis of dementia with Lewy bodies. PMID: 25632881 [NOT CITED] [LATEST Version]
  41. Driving assessment for maintaining mobility and safety in drivers with dementia. PMID: 23990315 [NOT CITED] [LATEST Version]
  42. Driving assessment for maintaining mobility and safety in drivers with dementia. PMID: 23728659 [NOT CITED] [OLD Version]
  43. Driving assessment for maintaining mobility and safety in drivers with dementia. PMID: 19160270 [NOT CITED] [OLD Version]
  44. Effect of the treatment of Type 2 diabetes mellitus on the development of cognitive impairment and dementia. PMID: 28617932 [NOT CITED] [LATEST Version]
  45. Effect of the treatment of Type II diabetes mellitus on the development of cognitive impairment and dementia. PMID: 12519608 [NOT CITED] [LATEST Version]
  46. Efficacy and experiences of telephone counselling for informal carers of people with dementia. PMID: 25177838 [NOT CITED] [LATEST Version]
  47. Efficacy of nicergoline in dementia and other age associated forms of cognitive impairment. PMID: 11687175 [NOT CITED] [LATEST Version]
  48. Enhanced rehabilitation and care models for adults with dementia following hip fracture surgery. PMID: 26074478 [NOT CITED] [LATEST Version]
  49. Enteral tube feeding for older people with advanced dementia. PMID: 19370678 [CITED] [LATEST Version]
  50. Environmental and behavioural modifications for improving food and fluid intake in people with dementia. PMID: 30021248 [NOT CITED] [LATEST Version]
  51. Exercise programs for people with dementia. PMID: 25874613 [CITED] [LATEST Version]
  52. Exercise programs for people with dementia. PMID: 24302466 [NOT CITED] [OLD Version]
  53. Folic acid with or without vitamin B12 for cognition and dementia. PMID: 14584018 [NOT CITED] [LATEST Version]
  54. Functional analysis-based interventions for challenging behaviour in dementia. PMID: 22336826 [NOT CITED] [LATEST Version]
  55. Galantamine for dementia in people with Down syndrome. PMID: 19160342 [NOT CITED] [LATEST Version]
  56. Ginkgo biloba for cognitive impairment and dementia. PMID: 19160216 [NOT CITED] [LATEST Version]
  57. Ginkgo biloba for cognitive impairment and dementia. PMID: 17443523 [NOT CITED] [OLD Version]
  58. Ginkgo biloba for cognitive impairment and dementia. PMID: 12519586 [NOT CITED] [OLD Version]
  59. Haloperidol for agitation in dementia. PMID: 12076456 [NOT CITED] [LATEST Version]
  60. Haloperidol for agitation in dementia. PMID: 11687166 [NOT CITED] [OLD Version]
  61. Homeopathy for dementia. PMID: 12535487 [NOT CITED] [LATEST Version]
  62. Hormone replacement therapy to maintain cognitive function in women with dementia. PMID: 19160224 [NOT CITED] [LATEST Version]
  63. Hormone replacement therapy to maintain cognitive function in women with dementia. PMID: 12137718 [NOT CITED] [OLD Version]
  64. Huperzine A for vascular dementia. PMID: 19370686 [NOT CITED] [LATEST Version]
  65. Hydergine for dementia. PMID: 11405961 [NOT CITED] [LATEST Version]
  66. Hydergine for dementia. PMID: 10796534 [NOT CITED] [OLD Version]
  67. Hyperbaric oxygen therapy for vascular dementia. PMID: 22786527 [NOT CITED] [LATEST Version]
  68. Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE) for the diagnosis of dementia within a general practice (primary care) setting. PMID: 24990271 [NOT CITED] [LATEST Version]
  69. Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE) for the diagnosis of dementia within a secondary care setting. PMID: 25754745 [NOT CITED] [LATEST Version]
  70. Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE) for the diagnosis of dementia within community dwelling populations. PMID: 24719028 [NOT CITED] [LATEST Version]
  71. Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE) for the early diagnosis of dementia across a variety of healthcare settings. PMID: 27869298 [CITED] [LATEST Version]
  72. Lecithin for dementia and cognitive impairment. PMID: 12917896 [NOT CITED] [LATEST Version]
  73. Lecithin for dementia and cognitive impairment. PMID: 11034695 [NOT CITED] [OLD Version]
  74. Lecithin for dementia and cognitive impairment. PMID: 10796586 [NOT CITED] [OLD Version]
  75. Light therapy for improving cognition, activities of daily living, sleep, challenging behaviour, and psychiatric disturbances in dementia. PMID: 24574061 [NOT CITED] [LATEST Version]
  76. Light therapy for managing cognitive, sleep, functional, behavioural, or psychiatric disturbances in dementia. PMID: 19821317 [NOT CITED] [LATEST Version]
  77. Light therapy for managing sleep, behaviour, and mood disturbances in dementia. PMID: 15106228 [NOT CITED] [LATEST Version]
  78. Massage and touch for dementia. PMID: 17054228 [CITED] [LATEST Version]
  79. Memantine for dementia in people with Down syndrome. PMID: 19160343 [NOT CITED] [LATEST Version]
  80. Memantine for dementia. PMID: 30891742 [NOT CITED] [LATEST Version]
  81. Memantine for dementia. PMID: 16625572 [NOT CITED] [OLD Version]
  82. Memantine for dementia. PMID: 16034889 [NOT CITED] [OLD Version]
  83. Memantine for dementia. PMID: 15846650 [NOT CITED] [OLD Version]
  84. Memantine for dementia. PMID: 15495043 [NOT CITED] [OLD Version]
  85. Memantine for dementia. PMID: 12917950 [NOT CITED] [OLD Version]
  86. Memantine for dementia. PMID: 12535459 [NOT CITED] [OLD Version]
  87. Metal protein attenuating compounds for the treatment of Alzheimer's dementia. PMID: 24563468 [NOT CITED] [LATEST Version]
  88. Metal protein attenuating compounds for the treatment of Alzheimer's dementia. PMID: 22592705 [NOT CITED] [OLD Version]
  89. Mindfulness-based stress reduction for family carers of people with dementia. PMID: 30106471 [NOT CITED] [LATEST Version]
  90. Mini-Cog for the diagnosis of Alzheimer's disease dementia and other dementias within a community setting. PMID: 25922857 [NOT CITED] [LATEST Version]
  91. Mini-Cog for the diagnosis of Alzheimer's disease dementia and other dementias within a primary care setting. PMID: 29470861 [NOT CITED] [LATEST Version]
  92. Mini-Cog for the diagnosis of Alzheimer's disease dementia and other dementias within a secondary care setting. PMID: 31521064 [NOT CITED] [LATEST Version]
  93. Mini-Mental State Examination (MMSE) for the detection of dementia in clinically unevaluated people aged 65 and over in community and primary care populations. PMID: 26760674 [CITED] [LATEST Version]
  94. Modifying the consistency of food and fluids for swallowing difficulties in dementia. PMID: 30251253 [NOT CITED] [LATEST Version]
  95. Music therapy for dementia symptoms. PMID: 10796604 [NOT CITED] [OLD Version]
  96. Music therapy for dementia symptoms. PMID: 10908486 [NOT CITED] [LATEST Version]
  97. Music therapy for people with dementia. PMID: 15266489 [NOT CITED] [LATEST Version]
  98. Music-based therapeutic interventions for people with dementia. PMID: 30033623 [CITED] [LATEST Version]
  99. Music-based therapeutic interventions for people with dementia. PMID: 28462986 [NOT CITED] [OLD Version]
  100. Naftidrofuryl for dementia. PMID: 22161372 [NOT CITED] [LATEST Version]
  101. Neuropsychological tests for the diagnosis of Alzheimer's disease dementia and other dementias: a generic protocol for cross-sectional and delayed-verification studies. PMID: 25177209 [NOT CITED] [LATEST Version]
  102. Nimodipine for primary degenerative, mixed and vascular dementia. PMID: 12137606 [NOT CITED] [LATEST Version]
  103. Nimodipine for primary degenerative, mixed and vascular dementia. PMID: 11279679 [NOT CITED] [OLD Version]
  104. Nimodipine for primary degenerative, mixed and vascular dementia. PMID: 10796495 [NOT CITED] [OLD Version]
  105. Non-pharmacological interventions for wandering of people with dementia in the domestic setting. PMID: 17253573 [NOT CITED] [LATEST Version]
  106. Omega 3 fatty acid for the prevention of cognitive decline and dementia. PMID: 22696350 [NOT CITED] [LATEST Version]
  107. Omega 3 fatty acid for the prevention of dementia. PMID: 16437528 [NOT CITED] [LATEST Version]
  108. Omega-3 fatty acids for the treatment of dementia. PMID: 27063583 [CITED] [LATEST Version]
  109. Opioids for agitation in dementia. PMID: 25972091 [NOT CITED] [LATEST Version]
  110. Palliative care interventions in advanced dementia. PMID: 27911489 [CITED] [LATEST Version]
  111. Personal assistance for older adults (65+) without dementia. PMID: 18254118 [NOT CITED] [LATEST Version]
  112. Personally tailored activities for improving psychosocial outcomes for people with dementia in long-term care. PMID: 29438597 [NOT CITED] [LATEST Version]
  113. Pharmacotherapies for sleep disturbances in dementia. PMID: 27851868 [CITED] [LATEST Version]
  114. Physical activity programs for persons with dementia. PMID: 18646158 [NOT CITED] [LATEST Version]
  115. Piracetam for dementia or cognitive impairment. PMID: 11405971 [NOT CITED] [LATEST Version]
  116. Piracetam for dementia or cognitive impairment. PMID: 10796585 [NOT CITED] [OLD Version]
  117. Plasma and cerebrospinal fluid amyloid beta for the diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI). PMID: 24913723 [NOT CITED] [LATEST Version]
  118. Procaine treatments for cognition and dementia. PMID: 18843698 [NOT CITED] [LATEST Version]
  119. Propentofylline for dementia. PMID: 12804440 [NOT CITED] [LATEST Version]
  120. Psychological treatments for depression and anxiety in dementia and mild cognitive impairment. PMID: 24449085 [NOT CITED] [LATEST Version]
  121. Reality orientation for dementia. PMID: 11034699 [NOT CITED] [LATEST Version]
  122. Reality orientation for dementia. PMID: 10796602 [NOT CITED] [OLD Version]
  123. Regional cerebral blood flow single photon emission computed tomography for detection of Frontotemporal dementia in people with suspected dementia. PMID: 26102272 [NOT CITED] [LATEST Version]
  124. Reminiscence therapy for dementia. PMID: 29493789 [CITED] [LATEST Version]
  125. Reminiscence therapy for dementia. PMID: 15846613 [NOT CITED] [OLD Version]
  126. Reminiscence therapy for dementia. PMID: 11034700 [NOT CITED] [OLD Version]
  127. Reminiscence therapy for dementia. PMID: 10796603 [NOT CITED] [OLD Version]
  128. Respite care for people with dementia and their carers. PMID: 24435941 [NOT CITED] [LATEST Version]
  129. Respite care for people with dementia and their carers. PMID: 15106250 [NOT CITED] [OLD Version]
  130. Rivastigmine for dementia in people with Down syndrome. PMID: 19160344 [NOT CITED] [LATEST Version]
  131. Simulated presence therapy for dementia. PMID: 28418586 [NOT CITED] [LATEST Version]
  132. Snoezelen for dementia. PMID: 12519587 [NOT CITED] [LATEST Version]
  133. Special care units for dementia individuals with behavioural problems. PMID: 19821370 [NOT CITED] [LATEST Version]
  134. Statin withdrawal in people with dementia. PMID: 27610945 [NOT CITED] [LATEST Version]
  135. Statins for the prevention of dementia. PMID: 26727124 [NOT CITED] [LATEST Version]
  136. Statins for the prevention of dementia. PMID: 19370582 [NOT CITED] [OLD Version]
  137. Statins for the treatment of dementia. PMID: 25004278 [CITED] [LATEST Version]
  138. Statins for the treatment of dementia. PMID: 20687089 [NOT CITED] [OLD Version]
  139. Support for carers of people with Alzheimer's type dementia. PMID: 10796545 [NOT CITED] [LATEST Version]
  140. The effects of blood pressure lowering on development of cognitive impairment and dementia in patients without apparent prior cerebrovascular disease. PMID: 16625595 [NOT CITED] [LATEST Version]
  141. Thioridazine for dementia. PMID: 11686961 [NOT CITED] [LATEST Version]
  142. Thioridazine for dementia. PMID: 10796547 [NOT CITED] [OLD Version]
  143. Traditional Chinese herbal medicine for vascular dementia. PMID: 30520514 [NOT CITED] [LATEST Version]
  144. Transcutaneous electrical nerve stimulation (TENS) for dementia. PMID: 12917999 [NOT CITED] [LATEST Version]
  145. Trazodone for agitation in dementia. PMID: 15495135 [NOT CITED] [LATEST Version]
  146. Validation therapy for dementia. PMID: 12917907 [CITED] [LATEST Version]
  147. Validation therapy for dementia. PMID: 10796644 [NOT CITED] [OLD Version]
  148. Valproate preparations for agitation in dementia. PMID: 30293233 [NOT CITED] [LATEST Version]
  149. Valproate preparations for agitation in dementia. PMID: 19588348 [NOT CITED] [OLD Version]
  150. Valproic acid for agitation in dementia. PMID: 15106227 [NOT CITED] [LATEST Version]
  151. Vinpocetine for cognitive impairment and dementia. PMID: 12535455 [NOT CITED] [LATEST Version]
  152. Vitamin and mineral supplementation for preventing dementia or delaying cognitive decline in people with mild cognitive impairment. PMID: 30383288 [NOT CITED] [LATEST Version]
  153. Vitamin E for Alzheimer's dementia and mild cognitive impairment. PMID: 28418065 [NOT CITED] [LATEST Version]
  154. Vitamin E for Alzheimer's dementia and mild cognitive impairment. PMID: 28128435 [NOT CITED] [OLD Version]
  155. Vitamin E for Alzheimer's dementia and mild cognitive impairment. PMID: 23152215 [NOT CITED] [OLD Version]
  156. Withdrawal versus continuation of chronic antipsychotic drugs for behavioural and psychological symptoms in older people with dementia. PMID: 23543555 [CITED] [LATEST Version]
  157. Withdrawal versus continuation of long-term antipsychotic drug use for behavioural and psychological symptoms in older people with dementia. PMID: 29605970 [NOT CITED] [LATEST Version]
  158. Yizhi capsule for vascular dementia. PMID: 17443586 [NOT CITED] [LATEST Version]
  159. Zhiling decoction for vascular dementia. PMID: 15495123 [NOT CITED] [LATEST Version]
  160. ¹⁸F-FDG PET for the early diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI). PMID: 25629415 [NOT CITED] [LATEST Version]
4267 Q11085 Parkinson disease Parkinson's disease FA 1-Top

Neurology

Psychiatry
  1. A comparison of physiotherapy techniques for patients with Parkinson's disease. PMID: 11279765 [NOT CITED] [LATEST Version]
  2. A comparison of speech and language therapy techniques for dysarthria in Parkinson's disease. PMID: 11406045 [NOT CITED] [LATEST Version]
  3. Amantadine for dyskinesia in Parkinson's disease. PMID: 12804468 [NOT CITED] [LATEST Version]
  4. Amantadine in Parkinson's disease. PMID: 12535476 [NOT CITED] [LATEST Version]
  5. Anti-hypertensive drugs as disease-modifying agents for Parkinson's disease: evidence from observational studies and clinical trials. PMID: 22071852 [NOT CITED] [LATEST Version]
  6. Anticholinergics for symptomatic management of Parkinson's disease. PMID: 12804486 [NOT CITED] [LATEST Version]
  7. Benzodiazepines and related drugs for insomnia in palliative care. PMID: 12519593 [NOT CITED] [LATEST Version]
  8. Beta-blocker therapy for tremor in Parkinson's disease. PMID: 12535472 [NOT CITED] [LATEST Version]
  9. Bromocriptine for levodopa-induced motor complications in Parkinson's disease. PMID: 10796755 [NOT CITED] [LATEST Version]
  10. Bromocriptine versus levodopa in early Parkinson's disease. PMID: 17943771 [NOT CITED] [LATEST Version]
  11. Bromocriptine versus levodopa in early Parkinson's disease. PMID: 10908538 [NOT CITED] [OLD Version]
  12. Bromocriptine/levodopa combined versus levodopa alone for early Parkinson's disease. PMID: 17943795 [NOT CITED] [LATEST Version]
  13. Bromocriptine/levodopa combined versus levodopa alone for early Parkinson's disease. PMID: 12076493 [NOT CITED] [OLD Version]
  14. Cabergoline for levodopa-induced complications in Parkinson's disease. PMID: 11279720 [NOT CITED] [LATEST Version]
  15. Cabergoline versus bromocriptine for levodopa-induced complications in Parkinson's disease. PMID: 11279721 [NOT CITED] [LATEST Version]
  16. Catechol-O-methyltransferase inhibitors for levodopa-induced complications in Parkinson's disease. PMID: 15495119 [NOT CITED] [LATEST Version]
  17. Catechol-O-methyltransferase inhibitors versus active comparators for levodopa-induced complications in Parkinson's disease. PMID: 15495118 [NOT CITED] [LATEST Version]
  18. Cholinesterase inhibitors for dementia with Lewy bodies, Parkinson's disease dementia and cognitive impairment in Parkinson's disease. PMID: 22419314 [NOT CITED] [LATEST Version]
  19. Cholinesterase inhibitors for Parkinson's disease dementia. PMID: 16437494 [NOT CITED] [LATEST Version]
  20. Cholinesterase inhibitors for rarer dementias associated with neurological conditions. PMID: 25734590 [NOT CITED] [LATEST Version]
  21. Coenzyme Q10 for Parkinson's disease. PMID: 22161420 [NOT CITED] [LATEST Version]
  22. Comparison of speech and language therapy techniques for speech problems in Parkinson's disease. PMID: 22895931 [NOT CITED] [LATEST Version]
  23. Creatine for Parkinson's disease. PMID: 24934384 [NOT CITED] [LATEST Version]
  24. Cytidinediphosphocholine (CDP-choline) for cognitive and behavioural disturbances associated with chronic cerebral disorders in the elderly. PMID: 15846601 [NOT CITED] [LATEST Version]
  25. Dopamine agents for hepatic encephalopathy. PMID: 24515383 [NOT CITED] [LATEST Version]
  26. Dopamine agonist therapy in early Parkinson's disease. PMID: 18425954 [NOT CITED] [LATEST Version]
  27. Electroconvulsive therapy for the depressed elderly. PMID: 12804479 [NOT CITED] [LATEST Version]
  28. Eszopiclone for insomnia. PMID: 30303519 [NOT CITED] [LATEST Version]
  29. Evaluation of the efficacy and safety of adjuvant treatment to levodopa therapy in Parkinson s disease patients with motor complications. PMID: 20614454 [NOT CITED] [LATEST Version]
  30. Helicobacter pylori eradication for Parkinson's disease. PMID: 22071847 [NOT CITED] [LATEST Version]
  31. Interventions for fatigue and weight loss in adults with advanced progressive illness. PMID: 22258985 [NOT CITED] [LATEST Version]
  32. Interventions for fatigue in Parkinson's disease. PMID: 26447539 [CITED] [LATEST Version]
  33. Lisuride for levodopa-induced complications in Parkinson's disease. PMID: 10796801 [NOT CITED] [LATEST Version]
  34. Lisuride versus bromocriptine for levodopa-induced complications in Parkinson's disease. PMID: 10796800 [NOT CITED] [LATEST Version]
  35. Management of faecal incontinence and constipation in adults with central neurological diseases. PMID: 24420006 [NOT CITED] [LATEST Version]
  36. Management of faecal incontinence and constipation in adults with central neurological diseases. PMID: 24347087 [NOT CITED] [OLD Version]
  37. Management of faecal incontinence and constipation in adults with central neurological diseases. PMID: 16625555 [NOT CITED] [OLD Version]
  38. Management of faecal incontinence and constipation in adults with central neurological diseases. PMID: 11687140 [NOT CITED] [OLD Version]
  39. Memantine for dementia. PMID: 30891742 [NOT CITED] [LATEST Version]
  40. Modifying the consistency of food and fluids for swallowing difficulties in dementia. PMID: 30251253 [NOT CITED] [LATEST Version]
  41. Monoamine oxidase B inhibitors for early Parkinson's disease. PMID: 16034956 [NOT CITED] [LATEST Version]
  42. Monoamine oxidase B inhibitors versus other dopaminergic agents in early Parkinson's disease. PMID: 19821381 [NOT CITED] [LATEST Version]
  43. Montreal Cognitive Assessment for the diagnosis of Alzheimer's disease and other dementias. PMID: 26513331 [NOT CITED] [LATEST Version]
  44. Non-pharmacological therapies for dysphagia in Parkinson's disease. PMID: 11279766 [NOT CITED] [LATEST Version]
  45. Non-steroidal anti-inflammatory drugs as disease-modifying agents for Parkinson's disease: evidence from observational studies. PMID: 22071848 [NOT CITED] [LATEST Version]
  46. Occupational therapy for patients with Parkinson's disease. PMID: 17636709 [CITED] [LATEST Version]
  47. Occupational therapy for patients with Parkinson's disease. PMID: 11687028 [NOT CITED] [OLD Version]
  48. Omega-3 fatty acids for the treatment of dementia. PMID: 27063583 [NOT CITED] [LATEST Version]
  49. Opioids for restless legs syndrome. PMID: 27355187 [NOT CITED] [LATEST Version]
  50. Pergolide for levodopa-induced complications in Parkinson's disease. PMID: 10796704 [NOT CITED] [LATEST Version]
  51. Pergolide versus bromocriptine for levodopa-induced motor complications in Parkinson's disease. PMID: 10796705 [NOT CITED] [LATEST Version]
  52. Physiotherapy for Parkinson's disease: a comparison of techniques. PMID: 24936965 [NOT CITED] [LATEST Version]
  53. Physiotherapy for patients with Parkinson's Disease: a comparison of techniques. PMID: 11687029 [NOT CITED] [LATEST Version]
  54. Physiotherapy versus placebo or no intervention in Parkinson's disease. PMID: 24018704 [NOT CITED] [LATEST Version]
  55. Physiotherapy versus placebo or no intervention in Parkinson's disease. PMID: 22895932 [NOT CITED] [OLD Version]
  56. Physiotherapy versus placebo or no intervention in Parkinson's disease. PMID: 22786482 [NOT CITED] [OLD Version]
  57. Pramipexole for levodopa-induced complications in Parkinson's disease. PMID: 10908540 [NOT CITED] [LATEST Version]
  58. Pramipexole versus bromocriptine for levodopa-induced complications in Parkinson's disease. PMID: 10908539 [NOT CITED] [LATEST Version]
  59. Ropinirole for levodopa-induced complications in Parkinson's disease. PMID: 11279718 [NOT CITED] [LATEST Version]
  60. Ropinirole for levodopa-induced complications in Parkinson's disease. PMID: 10908503 [NOT CITED] [OLD Version]
  61. Ropinirole versus bromocriptine for levodopa-induced complications in Parkinson's disease. PMID: 11279719 [NOT CITED] [LATEST Version]
  62. Ropinirole versus bromocriptine for levodopa-induced complications in Parkinson's disease. PMID: 10908504 [NOT CITED] [OLD Version]
  63. Selegiline for Alzheimer's disease. PMID: 12535396 [NOT CITED] [LATEST Version]
  64. Speech and language therapy for dysarthria in Parkinson's disease. PMID: 11406044 [NOT CITED] [LATEST Version]
  65. Speech and language therapy versus placebo or no intervention for speech problems in Parkinson's disease. PMID: 22895930 [NOT CITED] [LATEST Version]
  66. Therapies for depression in Parkinson's disease. PMID: 12917968 [NOT CITED] [LATEST Version]
  67. Transcranial direct current stimulation (tDCS) for idiopathic Parkinson's disease. PMID: 27425786 [NOT CITED] [LATEST Version]
  68. Treadmill training for patients with Parkinson's disease. PMID: 26363646 [NOT CITED] [LATEST Version]
  69. Treadmill training for patients with Parkinson's disease. PMID: 26297797 [NOT CITED] [OLD Version]
  70. Treadmill training for patients with Parkinson's disease. PMID: 20091652 [NOT CITED] [OLD Version]
  71. Virtual reality for rehabilitation in Parkinson's disease. PMID: 28000926 [NOT CITED] [LATEST Version]
  72. Whole-body vibration training for patients with neurodegenerative disease. PMID: 22336858 [NOT CITED] [LATEST Version]
4266 Q11081 Alzheimer's disease Alzheimer's disease FA 1-Top

Neurology

Psychiatry
  1. (11)C-PIB-PET for the early diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI). PMID: 25052054 [CITED] [LATEST Version]
  2. 18F PET with florbetaben for the early diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI). PMID: 29164600 [NOT CITED] [LATEST Version]
  3. 18F PET with florbetapir for the early diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI). PMID: 29164603 [NOT CITED] [LATEST Version]
  4. 18F PET with flutemetamol for the early diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI). PMID: 29164602 [NOT CITED] [LATEST Version]
  5. Acetyl-L-carnitine for dementia. PMID: 12804452 [NOT CITED] [LATEST Version]
  6. Alpha lipoic acid for dementia. PMID: 14974062 [NOT CITED] [LATEST Version]
  7. Antidepressants for agitation and psychosis in dementia. PMID: 21328305 [NOT CITED] [LATEST Version]
  8. Aspirin, steroidal and non-steroidal anti-inflammatory drugs for the treatment of Alzheimer's disease. PMID: 22336816 [NOT CITED] [LATEST Version]
  9. Blood pressure lowering in patients without prior cerebrovascular disease for prevention of cognitive impairment and dementia. PMID: 19821318 [NOT CITED] [LATEST Version]
  10. Cannabinoids for the treatment of dementia. PMID: 19370677 [CITED] [LATEST Version]
  11. Cerebrolysin for vascular dementia. PMID: 23440834 [NOT CITED] [LATEST Version]
  12. Cholinergic medication for antipsychotic-induced tardive dyskinesia. PMID: 29553158 [NOT CITED] [LATEST Version]
  13. Cholinergic medication for neuroleptic-induced tardive dyskinesia. PMID: 12137608 [NOT CITED] [LATEST Version]
  14. Cholinesterase inhibitors for Alzheimer's disease. PMID: 16437532 [CITED] [LATEST Version]
  15. Cholinesterase inhibitors for dementia with Lewy bodies, Parkinson's disease dementia and cognitive impairment in Parkinson's disease. PMID: 22419314 [NOT CITED] [LATEST Version]
  16. Cholinesterase inhibitors for rarer dementias associated with neurological conditions. PMID: 25734590 [NOT CITED] [LATEST Version]
  17. Clioquinol for the treatment of Alzheimer's Disease. PMID: 16437529 [NOT CITED] [LATEST Version]
  18. Cognitive rehabilitation and cognitive training for early-stage Alzheimer's disease and vascular dementia. PMID: 14583963 [NOT CITED] [LATEST Version]
  19. Cognitive training and cognitive rehabilitation for mild to moderate Alzheimer's disease and vascular dementia. PMID: 23740535 [NOT CITED] [LATEST Version]
  20. Community-based supplementary feeding for food insecure, vulnerable and malnourished populations - an overview of systematic reviews. PMID: 30480324 [NOT CITED] [LATEST Version]
  21. CSF tau and the CSF tau/ABeta ratio for the diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI). PMID: 28328043 [NOT CITED] [LATEST Version]
  22. D-cycloserine for Alzheimer's disease. PMID: 12076471 [NOT CITED] [LATEST Version]
  23. Dance movement therapy for dementia. PMID: 28155990 [NOT CITED] [LATEST Version]
  24. Dehydroepiandrosterone (DHEA) supplementation for cognition and well-being. PMID: 10796526 [NOT CITED] [LATEST Version]
  25. Dehydroepiandrosterone (DHEA) supplementation for cognitive function . PMID: 11405958 [NOT CITED] [LATEST Version]
  26. Donepezil for dementia due to Alzheimer's disease. PMID: 29923184 [CITED] [LATEST Version]
  27. Donepezil for dementia due to Alzheimer's disease. PMID: 16437430 [NOT CITED] [OLD Version]
  28. Donepezil for dementia due to Alzheimer's disease. PMID: 12917900 [NOT CITED] [OLD Version]
  29. Donepezil for mild and moderate Alzheimer's disease. PMID: 10796620 [NOT CITED] [OLD Version]
  30. Donepezil for mild and moderate Alzheimer's disease. PMID: 11034704 [NOT CITED] [LATEST Version]
  31. Donepezil for mild cognitive impairment. PMID: 16856114 [NOT CITED] [LATEST Version]
  32. Donepezil for vascular cognitive impairment. PMID: 14974068 [NOT CITED] [LATEST Version]
  33. Dopamine transporter imaging for the diagnosis of dementia with Lewy bodies. PMID: 25632881 [NOT CITED] [LATEST Version]
  34. Drug therapy for obstructive sleep apnoea in adults. PMID: 23728641 [NOT CITED] [LATEST Version]
  35. Efficacy and safety of nicotine on Alzheimer's disease patients. PMID: 11406005 [NOT CITED] [LATEST Version]
  36. Efficacy of nicergoline in dementia and other age associated forms of cognitive impairment. PMID: 11687175 [NOT CITED] [LATEST Version]
  37. Environmental and behavioural modifications for improving food and fluid intake in people with dementia. PMID: 30021248 [NOT CITED] [LATEST Version]
  38. Folic acid with or without vitamin B12 for cognition and dementia. PMID: 14584018 [NOT CITED] [LATEST Version]
  39. Folic acid with or without vitamin B12 for the prevention and treatment of healthy elderly and demented people. PMID: 18843658 [CITED] [LATEST Version]
  40. Galantamine for Alzheimer's disease and mild cognitive impairment. PMID: 16437436 [NOT CITED] [LATEST Version]
  41. Galantamine for Alzheimer's disease. PMID: 15495017 [NOT CITED] [LATEST Version]
  42. Galantamine for Alzheimer's disease. PMID: 12137632 [NOT CITED] [OLD Version]
  43. Galantamine for Alzheimer's disease. PMID: 11279727 [NOT CITED] [OLD Version]
  44. Galantamine for Alzheimer's disease. PMID: 11687119 [NOT CITED] [OLD Version]
  45. Galantamine for vascular cognitive impairment. PMID: 23862185 [NOT CITED] [LATEST Version]
  46. Galantamine for vascular cognitive impairment. PMID: 16437493 [NOT CITED] [OLD Version]
  47. Ginkgo biloba for cognitive impairment and dementia. PMID: 19160216 [CITED] [LATEST Version]
  48. Ginkgo biloba for tinnitus. PMID: 23543524 [NOT CITED] [LATEST Version]
  49. Hormone replacement therapy to maintain cognitive function in women with dementia. PMID: 19160224 [NOT CITED] [LATEST Version]
  50. Hormone replacement therapy to maintain cognitive function in women with dementia. PMID: 12137718 [NOT CITED] [OLD Version]
  51. Huperzine A for Alzheimer's disease. PMID: 18425924 [CITED] [LATEST Version]
  52. Huperzine A for mild cognitive impairment. PMID: 23235666 [NOT CITED] [LATEST Version]
  53. Ibuprofen for Alzheimer's disease. PMID: 12804498 [NOT CITED] [LATEST Version]
  54. Indomethacin for the treatment of Alzheimer's disease patients. PMID: 12076498 [NOT CITED] [LATEST Version]
  55. Latrepirdine for Alzheimer's disease. PMID: 25897825 [NOT CITED] [LATEST Version]
  56. Lecithin for dementia and cognitive impairment. PMID: 12917896 [NOT CITED] [LATEST Version]
  57. Lecithin for dementia and cognitive impairment. PMID: 11034695 [NOT CITED] [OLD Version]
  58. Lecithin for dementia and cognitive impairment. PMID: 10796586 [NOT CITED] [OLD Version]
  59. Management of faecal incontinence and constipation in adults with central neurological diseases. PMID: 24420006 [NOT CITED] [LATEST Version]
  60. Management of faecal incontinence and constipation in adults with central neurological diseases. PMID: 24347087 [NOT CITED] [OLD Version]
  61. Memantine for dementia. PMID: 30891742 [CITED] [LATEST Version]
  62. Memantine for dementia. PMID: 16625572 [NOT CITED] [OLD Version]
  63. Memantine for dementia. PMID: 16034889 [NOT CITED] [OLD Version]
  64. Memantine for dementia. PMID: 15846650 [NOT CITED] [OLD Version]
  65. Memantine for dementia. PMID: 15495043 [NOT CITED] [OLD Version]
  66. Memantine for dementia. PMID: 12917950 [NOT CITED] [OLD Version]
  67. Memantine for dementia. PMID: 12535459 [NOT CITED] [OLD Version]
  68. Metal protein attenuating compounds for the treatment of Alzheimer's dementia. PMID: 24563468 [NOT CITED] [LATEST Version]
  69. Metal protein attenuating compounds for the treatment of Alzheimer's dementia. PMID: 22592705 [NOT CITED] [OLD Version]
  70. Metal protein attenuating compounds for the treatment of Alzheimer's disease. PMID: 18254079 [NOT CITED] [LATEST Version]
  71. Metrifonate for Alzheimer's disease. PMID: 16625573 [NOT CITED] [LATEST Version]
  72. Mini-Cog for the diagnosis of Alzheimer's disease dementia and other dementias within a community setting. PMID: 25922857 [NOT CITED] [LATEST Version]
  73. Mini-Cog for the diagnosis of Alzheimer's disease dementia and other dementias within a primary care setting. PMID: 29470861 [NOT CITED] [LATEST Version]
  74. Mini-Cog for the diagnosis of Alzheimer's disease dementia and other dementias within a secondary care setting. PMID: 31521064 [NOT CITED] [LATEST Version]
  75. Mini-Mental State Examination (MMSE) for the detection of Alzheimer's disease and other dementias in people with mild cognitive impairment (MCI). PMID: 25740785 [NOT CITED] [LATEST Version]
  76. Montreal Cognitive Assessment for the diagnosis of Alzheimer's disease and other dementias. PMID: 26513331 [NOT CITED] [LATEST Version]
  77. Naftidrofuryl for dementia. PMID: 22161372 [NOT CITED] [LATEST Version]
  78. Neuropsychological tests for the diagnosis of Alzheimer's disease dementia and other dementias: a generic protocol for cross-sectional and delayed-verification studies. PMID: 25177209 [NOT CITED] [LATEST Version]
  79. Nicotine for Alzheimer's disease. PMID: 10796667 [NOT CITED] [LATEST Version]
  80. Nimodipine for primary degenerative, mixed and vascular dementia. PMID: 12137606 [NOT CITED] [LATEST Version]
  81. Nimodipine for primary degenerative, mixed and vascular dementia. PMID: 11279679 [NOT CITED] [OLD Version]
  82. Nimodipine for primary degenerative, mixed and vascular dementia. PMID: 10796495 [NOT CITED] [OLD Version]
  83. Omega-3 fatty acids for the treatment of dementia. PMID: 27063583 [CITED] [LATEST Version]
  84. Pharmacological interventions for apathy in Alzheimer's disease. PMID: 29727467 [NOT CITED] [LATEST Version]
  85. Pharmacological interventions for cognitive decline in people with Down syndrome. PMID: 26513128 [NOT CITED] [LATEST Version]
  86. Pharmacotherapies for sleep disturbances in Alzheimer's disease. PMID: 24659320 [NOT CITED] [LATEST Version]
  87. Pharmacotherapies for sleep disturbances in dementia. PMID: 27851868 [NOT CITED] [LATEST Version]
  88. Physostigmine for Alzheimer's disease. PMID: 11405996 [NOT CITED] [LATEST Version]
  89. Piracetam for dementia or cognitive impairment. PMID: 11405971 [NOT CITED] [LATEST Version]
  90. Piracetam for dementia or cognitive impairment. PMID: 10796585 [NOT CITED] [OLD Version]
  91. Plasma and cerebrospinal fluid amyloid beta for the diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI). PMID: 24913723 [NOT CITED] [LATEST Version]
  92. Processed electroencephalogram and evoked potential techniques for amelioration of postoperative delirium and cognitive dysfunction following non-cardiac and non-neurosurgical procedures in adults. PMID: 29761891 [NOT CITED] [LATEST Version]
  93. Propentofylline for dementia. PMID: 12804440 [NOT CITED] [LATEST Version]
  94. Regional cerebral blood flow single photon emission computed tomography for detection of Frontotemporal dementia in people with suspected dementia. PMID: 26102272 [NOT CITED] [LATEST Version]
  95. Rivastigmine for Alzheimer's disease. PMID: 26393402 [NOT CITED] [LATEST Version]
  96. Rivastigmine for Alzheimer's disease. PMID: 25858345 [CITED] [OLD Version] [UPDATE NEEDED]
  97. Rivastigmine for Alzheimer's disease. PMID: 19370562 [NOT CITED] [OLD Version]
  98. Rivastigmine for Alzheimer's disease. PMID: 11034705 [NOT CITED] [OLD Version]
  99. Rivastigmine for Alzheimer's disease. PMID: 10796621 [NOT CITED] [OLD Version]
  100. Rivastigmine for vascular cognitive impairment. PMID: 23728651 [NOT CITED] [LATEST Version]
  101. Rivastigmine for vascular cognitive impairment. PMID: 15846730 [NOT CITED] [OLD Version]
  102. Selegiline for Alzheimer's disease. PMID: 12535396 [NOT CITED] [LATEST Version]
  103. Selegiline for Alzheimer's disease. PMID: 10796544 [NOT CITED] [OLD Version]
  104. Special care units for dementia individuals with behavioural problems. PMID: 19821370 [NOT CITED] [LATEST Version]
  105. Statins for the prevention of Alzheimer's disease. PMID: 11687176 [NOT CITED] [LATEST Version]
  106. Statins for the prevention of dementia. PMID: 26727124 [NOT CITED] [LATEST Version]
  107. Statins for the prevention of dementia. PMID: 19370582 [NOT CITED] [OLD Version]
  108. Statins for the reduction of risk of Alzheimer's disease. PMID: 11687043 [NOT CITED] [LATEST Version]
  109. Statins for the treatment of dementia. PMID: 25004278 [CITED] [LATEST Version]
  110. Statins for the treatment of dementia. PMID: 20687089 [NOT CITED] [OLD Version]
  111. Support for carers of people with Alzheimer's type dementia. PMID: 10796545 [NOT CITED] [LATEST Version]
  112. Tacrine for Alzheimer's disease. PMID: 10796507 [NOT CITED] [OLD Version]
  113. Tacrine for Alzheimer's disease. PMID: 10908463 [NOT CITED] [LATEST Version]
  114. The effect of vitamin B6 on cognition. PMID: 14584010 [NOT CITED] [LATEST Version]
  115. The effectiveness of atypical antipsychotics for the treatment of aggression and psychosis in Alzheimer's disease. PMID: 16437455 [CITED] [LATEST Version]
  116. The effects of blood pressure lowering on development of cognitive impairment and dementia in patients without apparent prior cerebrovascular disease. PMID: 16625595 [NOT CITED] [LATEST Version]
  117. Thiamine for Alzheimer's disease. PMID: 11405995 [NOT CITED] [LATEST Version]
  118. Thiamine for Alzheimer's disease. PMID: 10796655 [NOT CITED] [OLD Version]
  119. Transcutaneous electrical nerve stimulation (TENS) for dementia. PMID: 12917999 [NOT CITED] [LATEST Version]
  120. Trazodone for agitation in dementia. PMID: 15495135 [NOT CITED] [LATEST Version]
  121. Treatment of epilepsy for people with Alzheimer's disease. PMID: 30570742 [NOT CITED] [LATEST Version]
  122. Treatment of epilepsy for people with Alzheimer's disease. PMID: 27805721 [NOT CITED] [OLD Version]
  123. Validation therapy for dementia. PMID: 10796644 [NOT CITED] [LATEST Version]
  124. Velnacrine for Alzheimer's disease. PMID: 15106259 [NOT CITED] [LATEST Version]
  125. Vinpocetine for cognitive impairment and dementia. PMID: 12535455 [NOT CITED] [LATEST Version]
  126. Vitamin B12 for cognition. PMID: 12918012 [NOT CITED] [LATEST Version]
  127. Vitamin E for Alzheimer's dementia and mild cognitive impairment. PMID: 28418065 [CITED] [LATEST Version]
  128. Vitamin E for Alzheimer's dementia and mild cognitive impairment. PMID: 28128435 [NOT CITED] [OLD Version]
  129. Vitamin E for Alzheimer's dementia and mild cognitive impairment. PMID: 23152215 [NOT CITED] [OLD Version]
  130. Vitamin E for Alzheimer's disease and mild cognitive impairment. PMID: 18646084 [NOT CITED] [LATEST Version]
  131. Vitamin E for Alzheimer's disease. PMID: 11034775 [NOT CITED] [LATEST Version]
  132. ¹⁸F-FDG PET for the early diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI). PMID: 25629415 [CITED] [LATEST Version]
209 Q181923 attention deficit hyperactivity disorder Attention deficit hyperactivity disorder GA 1-Top

Psychiatry
  1. Acupuncture for Attention Deficit Hyperactivity Disorder (ADHD) in children and adolescents. PMID: 21491402 [NOT CITED] [LATEST Version]
  2. Amfetamine for attention deficit hyperactivity disorder in people with intellectual disabilities. PMID: 19160313 [NOT CITED] [LATEST Version]
  3. Amphetamines for attention deficit hyperactivity disorder (ADHD) in adults. PMID: 30091808 [CITED] [LATEST Version]
  4. Amphetamines for Attention Deficit Hyperactivity Disorder (ADHD) in adults. PMID: 21678370 [NOT CITED] [OLD Version]
  5. Amphetamines for attention deficit hyperactivity disorder (ADHD) in children and adolescents. PMID: 26844979 [NOT CITED] [LATEST Version]
  6. Atypical antipsychotics for disruptive behaviour disorders in children and youths. PMID: 22972123 [NOT CITED] [LATEST Version]
  7. Bupropion for attention deficit hyperactivity disorder (ADHD) in adults. PMID: 28965364 [NOT CITED] [LATEST Version]
  8. Cognitive-behavioural interventions for attention deficit hyperactivity disorder (ADHD) in adults. PMID: 29566425 [NOT CITED] [LATEST Version]
  9. Family therapy for attention-deficit disorder or attention-deficit/hyperactivity disorder in children and adolescents. PMID: 15846741 [CITED] [LATEST Version]
  10. Homeopathy for attention deficit/hyperactivity disorder or hyperkinetic disorder. PMID: 17943868 [NOT CITED] [LATEST Version]
  11. Immediate-release methylphenidate for attention deficit hyperactivity disorder (ADHD) in adults. PMID: 25230710 [NOT CITED] [LATEST Version]
  12. Interventions for pathological gambling. PMID: 10796802 [NOT CITED] [LATEST Version]
  13. L-acetylcarnitine for treating fragile X syndrome. PMID: 25985235 [NOT CITED] [LATEST Version]
  14. Meditation therapies for attention-deficit/hyperactivity disorder (ADHD). PMID: 20556767 [NOT CITED] [LATEST Version]
  15. Methylphenidate for attention deficit hyperactivity disorder (ADHD) in children and adolescents - assessment of adverse events in non-randomised studies. PMID: 29744873 [CITED] [LATEST Version]
  16. Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD). PMID: 26599576 [CITED] [LATEST Version]
  17. Methylphenidate for children and adolescents with autism spectrum disorder. PMID: 29159857 [NOT CITED] [LATEST Version]
  18. Parent training interventions for Attention Deficit Hyperactivity Disorder (ADHD) in children aged 5 to 18 years. PMID: 22161373 [NOT CITED] [LATEST Version]
  19. Parent training interventions for attention deficit hyperactivity disorder. PMID: 25419178 [NOT CITED] [LATEST Version]
  20. Pharmacological treatment for attention deficit hyperactivity disorder (ADHD) in children with comorbid tic disorders. PMID: 29944175 [NOT CITED] [LATEST Version]
  21. Pharmacological treatment for Attention Deficit Hyperactivity Disorder (ADHD) in children with comorbid tic disorders. PMID: 21491404 [NOT CITED] [OLD Version]
  22. Polyunsaturated fatty acids (PUFA) for attention deficit hyperactivity disorder (ADHD) in children and adolescents. PMID: 22786509 [NOT CITED] [LATEST Version]
  23. Polyunsaturated fatty acids (PUFAs) for children with specific learning disorders. PMID: 27678554 [NOT CITED] [LATEST Version]
  24. Polyunsaturated fatty acids (PUFAs) for children with specific learning disorders. PMID: 23235675 [NOT CITED] [OLD Version]
  25. Pycnogenol(®) for the treatment of chronic disorders. PMID: 22336841 [NOT CITED] [LATEST Version]
  26. Pycnogenol® (extract of French maritime pine bark) for the treatment of chronic disorders. PMID: 22513958 [NOT CITED] [LATEST Version]
  27. Risperidone for attention-deficit hyperactivity disorder in people with intellectual disabilities. PMID: 19370667 [NOT CITED] [LATEST Version]
  28. Social skills training for attention deficit hyperactivity disorder (ADHD) in children aged 5 to 18 years. PMID: 31222721 [NOT CITED] [LATEST Version]
  29. Social skills training for Attention Deficit Hyperactivity Disorder (ADHD) in children aged 5 to 18 years. PMID: 22161422 [NOT CITED] [OLD Version]
  30. Tricyclic antidepressants for attention deficit hyperactivity disorder (ADHD) in children and adolescents. PMID: 25238582 [NOT CITED] [LATEST Version]
4594 Q41112 schizophrenia Schizophrenia FA 1-Top

Psychiatry
  1. Acetylcholinesterase inhibitors for schizophrenia. PMID: 22258978 [NOT CITED] [LATEST Version]
  2. Acetylsalicylic acid (aspirin) for schizophrenia. PMID: 31425623 [NOT CITED] [LATEST Version]
  3. Acupuncture for schizophrenia. PMID: 25330045 [NOT CITED] [LATEST Version]
  4. Acupuncture for schizophrenia. PMID: 16235404 [NOT CITED] [OLD Version]
  5. Amisulpride versus other atypical antipsychotics for schizophrenia. PMID: 20091599 [NOT CITED] [LATEST Version]
  6. Amphetamines for schizophrenia. PMID: 15495131 [NOT CITED] [LATEST Version]
  7. Anticholinergic medication for non-clozapine neuroleptic-induced hypersalivation in people with schizophrenia. PMID: 24353163 [NOT CITED] [LATEST Version]
  8. Antidepressants for the negative symptoms of schizophrenia. PMID: 16856105 [NOT CITED] [LATEST Version]
  9. Antioxidant treatments for schizophrenia. PMID: 26848926 [NOT CITED] [LATEST Version]
  10. Antipsychotic combinations for schizophrenia. PMID: 28658515 [NOT CITED] [LATEST Version]
  11. Antipsychotic combinations for schizophrenia. PMID: 25267895 [NOT CITED] [OLD Version]
  12. Antipsychotic drug treatment for elderly people with late-onset schizophrenia. PMID: 22336800 [NOT CITED] [LATEST Version]
  13. Antipsychotic medication for childhood-onset schizophrenia. PMID: 17636744 [NOT CITED] [LATEST Version]
  14. Antipsychotic medication for early episode schizophrenia. PMID: 21678355 [NOT CITED] [LATEST Version]
  15. Antipsychotic medication for elderly people with schizophrenia. PMID: 16437531 [NOT CITED] [LATEST Version]
  16. Antipsychotic medication versus placebo for people with both schizophrenia and learning disability. PMID: 15494985 [NOT CITED] [LATEST Version]
  17. Antipsychotic switching for people with schizophrenia who have neuroleptic-induced weight or metabolic problems. PMID: 21154372 [NOT CITED] [LATEST Version]
  18. Aripiprazole for schizophrenia. PMID: 16625607 [NOT CITED] [LATEST Version]
  19. Aripiprazole for schizophrenia. PMID: 15106256 [NOT CITED] [OLD Version]
  20. Aripiprazole versus other atypical antipsychotics for schizophrenia. PMID: 24385408 [NOT CITED] [LATEST Version]
  21. Aripiprazole versus other atypical antipsychotics for schizophrenia. PMID: 23450570 [NOT CITED] [OLD Version]
  22. Aripiprazole versus other atypical antipsychotics for schizophrenia. PMID: 19821375 [NOT CITED] [OLD Version]
  23. Aripiprazole versus placebo for schizophrenia. PMID: 21833956 [NOT CITED] [LATEST Version]
  24. Aripiprazole versus typical antipsychotic drugs for schizophrenia. PMID: 18646161 [NOT CITED] [LATEST Version]
  25. Aripiprazole versus typicals for schizophrenia. PMID: 18254107 [NOT CITED] [LATEST Version]
  26. Art therapy for schizophrenia or schizophrenia-like illnesses. PMID: 16235338 [CITED] [LATEST Version]
  27. Asenapine versus placebo for schizophrenia. PMID: 26599405 [NOT CITED] [LATEST Version]
  28. Atypical antipsychotics for people with both schizophrenia and depression. PMID: 18254078 [NOT CITED] [LATEST Version]
  29. Ayurvedic medicine for schizophrenia. PMID: 17943922 [NOT CITED] [LATEST Version]
  30. Benperidol for schizophrenia. PMID: 15846648 [NOT CITED] [LATEST Version]
  31. Benzodiazepines for catatonia in people with schizophrenia and other serious mental illnesses. PMID: 18843722 [NOT CITED] [LATEST Version]
  32. Benzodiazepines for catatonia in people with schizophrenia or other serious mental illnesses. PMID: 31425609 [NOT CITED] [LATEST Version]
  33. Benzodiazepines for schizophrenia. PMID: 23152236 [NOT CITED] [LATEST Version]
  34. Benzodiazepines for schizophrenia. PMID: 17253592 [NOT CITED] [OLD Version]
  35. Bifeprunox versus placebo for schizophrenia. PMID: 27732740 [NOT CITED] [LATEST Version]
  36. Bromperidol decanoate (depot) for schizophrenia. PMID: 23152208 [NOT CITED] [LATEST Version]
  37. Bromperidol decanoate (depot) for schizophrenia. PMID: 21901678 [NOT CITED] [OLD Version]
  38. Cannabis and schizophrenia. PMID: 25314586 [NOT CITED] [LATEST Version]
  39. Cannabis and schizophrenia. PMID: 18646115 [NOT CITED] [OLD Version]
  40. Carbamazepine for schizophrenia. PMID: 24789267 [NOT CITED] [LATEST Version]
  41. Carbamazepine for schizophrenia. PMID: 17636660 [NOT CITED] [OLD Version]
  42. Cessation of medication for people with schizophrenia already stable on chlorpromazine. PMID: 17253586 [NOT CITED] [LATEST Version]
  43. Chinese herbal medicine for schizophrenia. PMID: 16235320 [NOT CITED] [LATEST Version]
  44. Chlorpromazine dose for people with schizophrenia. PMID: 28407198 [NOT CITED] [LATEST Version]
  45. Chlorpromazine dose for people with schizophrenia. PMID: 19370692 [NOT CITED] [OLD Version]
  46. Chlorpromazine versus atypical antipsychotic drugs for schizophrenia. PMID: 27045703 [NOT CITED] [LATEST Version]
  47. Chlorpromazine versus clotiapine for schizophrenia. PMID: 28387925 [NOT CITED] [LATEST Version]
  48. Chlorpromazine versus metiapine for schizophrenia. PMID: 28349512 [NOT CITED] [LATEST Version]
  49. Chlorpromazine versus penfluridol for schizophrenia. PMID: 28940256 [NOT CITED] [LATEST Version]
  50. Chlorpromazine versus piperacetazine for schizophrenia. PMID: 30378678 [NOT CITED] [LATEST Version]
  51. Chlorpromazine versus placebo for schizophrenia. PMID: 24395698 [NOT CITED] [LATEST Version]
  52. Chlorpromazine versus placebo for schizophrenia. PMID: 17443500 [NOT CITED] [OLD Version]
  53. Chlorpromazine versus placebo for schizophrenia. PMID: 12804394 [NOT CITED] [OLD Version]
  54. Chlorpromazine versus reserpine for schizophrenia. PMID: 27124109 [NOT CITED] [LATEST Version]
  55. Clozapine combined with different antipsychotic drugs for treatment resistant schizophrenia. PMID: 19588385 [NOT CITED] [LATEST Version]
  56. Clozapine combined with different antipsychotic drugs for treatment-resistant schizophrenia. PMID: 28333365 [NOT CITED] [LATEST Version]
  57. Clozapine dose for schizophrenia. PMID: 28613395 [NOT CITED] [LATEST Version]
  58. Clozapine versus other atypical antipsychotics for schizophrenia. PMID: 21069690 [NOT CITED] [LATEST Version]
  59. Clozapine versus typical neuroleptic medication for schizophrenia. PMID: 19160174 [CITED] [LATEST Version]
  60. Cognitive behaviour therapy for schizophrenia. PMID: 15495000 [NOT CITED] [LATEST Version]
  61. Cognitive behaviour therapy versus other psychosocial treatments for schizophrenia. PMID: 22513966 [NOT CITED] [LATEST Version]
  62. Cognitive behavioural therapy (brief versus standard duration) for schizophrenia. PMID: 26488686 [NOT CITED] [LATEST Version]
  63. Cognitive behavioural therapy (brief versus standard duration) for schizophrenia. PMID: 24723312 [NOT CITED] [OLD Version]
  64. Cognitive behavioural therapy plus standard care versus standard care for people with schizophrenia. PMID: 30572373 [NOT CITED] [LATEST Version]
  65. Cognitive behavioural therapy plus standard care versus standard care plus other psychosocial treatments for people with schizophrenia. PMID: 30480760 [CITED] [LATEST Version]
  66. Compliance therapy for schizophrenia. PMID: 16856009 [NOT CITED] [LATEST Version]
  67. Dance therapy for schizophrenia. PMID: 24092546 [NOT CITED] [LATEST Version]
  68. Dance therapy for schizophrenia. PMID: 19160306 [NOT CITED] [OLD Version]
  69. Day hospital versus outpatient care for people with schizophrenia. PMID: 19821303 [NOT CITED] [LATEST Version]
  70. Depot bromperidol decanoate for schizophrenia. PMID: 15266450 [NOT CITED] [LATEST Version]
  71. Depot fluphenazine decanoate and enanthate for schizophrenia. PMID: 15674872 [NOT CITED] [LATEST Version]
  72. Depot fluspirilene for schizophrenia. PMID: 17253464 [NOT CITED] [LATEST Version]
  73. Depot perphenazine decanoate and enanthate for schizophrenia. PMID: 16034865 [NOT CITED] [LATEST Version]
  74. Depot pipotiazine palmitate and undecylenate for schizophrenia. PMID: 15495016 [NOT CITED] [LATEST Version]
  75. Depot risperidone for schizophrenia. PMID: 14584007 [NOT CITED] [LATEST Version]
  76. Dietary advice for people with schizophrenia. PMID: 27007216 [NOT CITED] [LATEST Version]
  77. Different communication strategies for disclosing a diagnosis of schizophrenia and related disorders. PMID: 29064090 [NOT CITED] [LATEST Version]
  78. Distraction techniques for schizophrenia. PMID: 15674963 [NOT CITED] [LATEST Version]
  79. Drama therapy for schizophrenia or schizophrenia-like illnesses. PMID: 17253555 [CITED] [LATEST Version]
  80. Electroconvulsive therapy for schizophrenia. PMID: 15846598 [NOT CITED] [LATEST Version]
  81. Electroconvulsive therapy for treatment-resistant schizophrenia. PMID: 30888709 [NOT CITED] [LATEST Version]
  82. Estrogen for schizophrenia. PMID: 16235377 [NOT CITED] [LATEST Version]
  83. Exercise therapy for schizophrenia. PMID: 20464730 [CITED] [LATEST Version]
  84. Family intervention (brief) for schizophrenia. PMID: 24595545 [NOT CITED] [LATEST Version]
  85. Family intervention for schizophrenia. PMID: 21154340 [CITED] [LATEST Version]
  86. Family intervention for schizophrenia. PMID: 17054127 [NOT CITED] [OLD Version]
  87. First rank symptoms for schizophrenia. PMID: 25879096 [NOT CITED] [LATEST Version]
  88. Flupenthixol decanoate (depot) for schizophrenia or other similar psychotic disorders. PMID: 24915451 [NOT CITED] [LATEST Version]
  89. Flupenthixol versus low-potency first-generation antipsychotic drugs for schizophrenia. PMID: 25177834 [NOT CITED] [LATEST Version]
  90. Flupenthixol versus placebo for schizophrenia. PMID: 23152280 [NOT CITED] [LATEST Version]
  91. Fluphenazine (oral) versus atypical antipsychotics for schizophrenia. PMID: 27370402 [NOT CITED] [LATEST Version]
  92. Fluphenazine (oral) versus placebo for schizophrenia. PMID: 29893410 [NOT CITED] [LATEST Version]
  93. Fluphenazine (oral) versus placebo for schizophrenia. PMID: 23861067 [NOT CITED] [OLD Version]
  94. Fluphenazine decanoate (depot) and enanthate for schizophrenia. PMID: 25654768 [NOT CITED] [LATEST Version]
  95. Fluphenazine versus low-potency first-generation antipsychotic drugs for schizophrenia. PMID: 25087165 [NOT CITED] [LATEST Version]
  96. Glutamatergic drugs for schizophrenia. PMID: 16625590 [NOT CITED] [LATEST Version]
  97. Haloperidol discontinuation for people with schizophrenia. PMID: 31006114 [NOT CITED] [LATEST Version]
  98. Haloperidol dose for the acute phase of schizophrenia. PMID: 23983042 [NOT CITED] [LATEST Version]
  99. Haloperidol versus chlorpromazine for schizophrenia. PMID: 18254045 [NOT CITED] [LATEST Version]
  100. Haloperidol versus first-generation antipsychotics for the treatment of schizophrenia and other psychotic disorders. PMID: 25592299 [NOT CITED] [LATEST Version]
  101. Haloperidol versus low-potency first-generation antipsychotic drugs for schizophrenia. PMID: 25007358 [NOT CITED] [LATEST Version]
  102. Haloperidol versus placebo for schizophrenia. PMID: 24242360 [NOT CITED] [LATEST Version]
  103. Haloperidol versus placebo for schizophrenia. PMID: 17054159 [NOT CITED] [OLD Version]
  104. Horticultural therapy for schizophrenia. PMID: 24842458 [NOT CITED] [LATEST Version]
  105. Hypnosis for schizophrenia. PMID: 17943812 [NOT CITED] [LATEST Version]
  106. Hypnosis for schizophrenia. PMID: 15266520 [NOT CITED] [OLD Version]
  107. Increasing antipsychotic dose for non response in schizophrenia. PMID: 29750432 [NOT CITED] [LATEST Version]
  108. Increasing antipsychotic dose versus switching antipsychotic for non response in schizophrenia. PMID: 29749607 [NOT CITED] [LATEST Version]
  109. Information and communication technology in patient education and support for people with schizophrenia. PMID: 23076932 [NOT CITED] [LATEST Version]
  110. Intermittent drug techniques for schizophrenia. PMID: 23881657 [NOT CITED] [LATEST Version]
  111. Interventions for obsessive compulsive symptoms in people with schizophrenia. PMID: 25267890 [NOT CITED] [LATEST Version]
  112. Interventions for smoking cessation and reduction in individuals with schizophrenia. PMID: 23450574 [NOT CITED] [LATEST Version]
  113. Interventions for smoking cessation and reduction in individuals with schizophrenia. PMID: 20556777 [NOT CITED] [OLD Version]
  114. Interventions to reduce weight gain in schizophrenia. PMID: 17253540 [NOT CITED] [LATEST Version]
  115. Lamotrigine for schizophrenia. PMID: 17054266 [NOT CITED] [LATEST Version]
  116. Levomepromazine for schizophrenia. PMID: 20927765 [NOT CITED] [LATEST Version]
  117. Lithium for schizophrenia. PMID: 26509923 [NOT CITED] [LATEST Version]
  118. Lithium for schizophrenia. PMID: 17636738 [NOT CITED] [OLD Version]
  119. Loxapine for schizophrenia. PMID: 17943763 [NOT CITED] [LATEST Version]
  120. Maintenance treatment with antipsychotic drugs for schizophrenia. PMID: 22592725 [NOT CITED] [LATEST Version]
  121. Mirtazapine adjunct for people with schizophrenia. PMID: 29802811 [NOT CITED] [LATEST Version]
  122. Molindone for schizophrenia and severe mental illness. PMID: 17253473 [NOT CITED] [LATEST Version]
  123. Monetary incentives for schizophrenia. PMID: 19821433 [NOT CITED] [LATEST Version]
  124. Morita therapy for schizophrenia. PMID: 17253588 [NOT CITED] [LATEST Version]
  125. Mother and baby units for schizophrenia. PMID: 17253587 [NOT CITED] [LATEST Version]
  126. Music therapy for people with schizophrenia and schizophrenia-like disorders. PMID: 28553702 [NOT CITED] [LATEST Version]
  127. Music therapy for people with schizophrenia and schizophrenia-like disorders. PMID: 22161383 [NOT CITED] [OLD Version]
  128. Music therapy for schizophrenia or schizophrenia-like illnesses. PMID: 15846692 [NOT CITED] [LATEST Version]
  129. Nicotine for schizophrenia. PMID: 16437497 [NOT CITED] [LATEST Version]
  130. Nidotherapy for people with schizophrenia. PMID: 23543583 [CITED] [LATEST Version]
  131. Occupational therapy delivered by specialists versus non-specialists for people with schizophrenia. PMID: 30293234 [NOT CITED] [LATEST Version]
  132. Olanzapine for schizophrenia. PMID: 15846619 [NOT CITED] [LATEST Version]
  133. Olanzapine versus other atypical antipsychotics for schizophrenia. PMID: 20238348 [NOT CITED] [LATEST Version]
  134. Oral fluphenazine versus placebo for schizophrenia. PMID: 17253589 [NOT CITED] [LATEST Version]
  135. Paliperidone for schizophrenia. PMID: 18425951 [NOT CITED] [LATEST Version]
  136. Paliperidone palmitate for schizophrenia. PMID: 22696377 [NOT CITED] [LATEST Version]
  137. Peer support for people with schizophrenia or other serious mental illness. PMID: 30946482 [CITED] [LATEST Version]
  138. Penfluridol for schizophrenia. PMID: 16625563 [NOT CITED] [LATEST Version]
  139. Perazine for schizophrenia. PMID: 24425538 [NOT CITED] [LATEST Version]
  140. Perazine for schizophrenia. PMID: 16625562 [NOT CITED] [OLD Version]
  141. Pericyazine for schizophrenia. PMID: 24825770 [NOT CITED] [LATEST Version]
  142. Perphenazine for schizophrenia. PMID: 25749632 [NOT CITED] [LATEST Version]
  143. Perphenazine for schizophrenia. PMID: 15674907 [NOT CITED] [OLD Version]
  144. Perphenazine versus low-potency first-generation antipsychotic drugs for schizophrenia. PMID: 25290157 [NOT CITED] [LATEST Version]
  145. Pimozide for schizophrenia or related psychoses. PMID: 24194433 [NOT CITED] [LATEST Version]
  146. Pimozide for schizophrenia or related psychoses. PMID: 17636692 [NOT CITED] [OLD Version]
  147. Polyunsaturated fatty acid supplementation for schizophrenia. PMID: 16855961 [NOT CITED] [LATEST Version]
  148. Polyunsaturated fatty acid supplementation for schizophrenia. PMID: 12804400 [NOT CITED] [OLD Version]
  149. Problem solving skills for schizophrenia. PMID: 17443621 [NOT CITED] [LATEST Version]
  150. Psychoeducation for schizophrenia. PMID: 21678337 [NOT CITED] [LATEST Version]
  151. Quetiapine for schizophrenia. PMID: 15106155 [NOT CITED] [LATEST Version]
  152. Quetiapine versus other atypical antipsychotics for schizophrenia. PMID: 24249315 [NOT CITED] [LATEST Version]
  153. Quetiapine versus other atypical antipsychotics for schizophrenia. PMID: 20091600 [NOT CITED] [OLD Version]
  154. Quetiapine versus typical antipsychotic medications for schizophrenia. PMID: 23728667 [NOT CITED] [LATEST Version]
  155. Risperidone (depot) for schizophrenia. PMID: 27078222 [NOT CITED] [LATEST Version]
  156. Risperidone dose for schizophrenia. PMID: 19821422 [NOT CITED] [LATEST Version]
  157. Risperidone versus olanzapine for schizophrenia. PMID: 16625629 [NOT CITED] [LATEST Version]
  158. Risperidone versus olanzapine for schizophrenia. PMID: 15846745 [NOT CITED] [OLD Version]
  159. Risperidone versus other atypical antipsychotics for schizophrenia. PMID: 21249678 [NOT CITED] [LATEST Version]
  160. Risperidone versus placebo for schizophrenia. PMID: 27977041 [NOT CITED] [LATEST Version]
  161. Risperidone versus placebo for schizophrenia. PMID: 20091611 [NOT CITED] [OLD Version]
  162. Risperidone versus typical antipsychotic medication for schizophrenia. PMID: 12804396 [NOT CITED] [LATEST Version]
  163. Selective noradrenaline reuptake inhibitors for schizophrenia. PMID: 29368813 [NOT CITED] [LATEST Version]
  164. Sertindole for schizophrenia. PMID: 16034864 [NOT CITED] [LATEST Version]
  165. Sertindole versus other atypical antipsychotics for schizophrenia. PMID: 19370652 [NOT CITED] [LATEST Version]
  166. Social skills programmes for schizophrenia. PMID: 26059249 [NOT CITED] [LATEST Version]
  167. Social skills programmes for schizophrenia. PMID: 25414592 [NOT CITED] [OLD Version]
  168. Sulpiride augmentation for schizophrenia. PMID: 20091661 [NOT CITED] [LATEST Version]
  169. Sulpiride versus placebo for schizophrenia. PMID: 24729184 [NOT CITED] [LATEST Version]
  170. Sulpiride versus placebo for schizophrenia. PMID: 19370694 [NOT CITED] [OLD Version]
  171. Supportive therapy for schizophrenia. PMID: 25871462 [NOT CITED] [LATEST Version]
  172. Supportive therapy for schizophrenia. PMID: 17636772 [NOT CITED] [OLD Version]
  173. Supportive therapy for schizophrenia. PMID: 17253519 [NOT CITED] [OLD Version]
  174. Testosterone for schizophrenia. PMID: 17636833 [NOT CITED] [LATEST Version]
  175. Thioridazine for schizophrenia. PMID: 17636691 [NOT CITED] [LATEST Version]
  176. Training to recognise the early signs of recurrence in schizophrenia. PMID: 23450559 [NOT CITED] [LATEST Version]
  177. Transcranial magnetic stimulation (TMS) for schizophrenia. PMID: 26289586 [CITED] [LATEST Version]
  178. Transcranial magnetic stimulation for schizophrenia. PMID: 25411556 [NOT CITED] [LATEST Version]
  179. Trifluoperazine for schizophrenia. PMID: 14974020 [NOT CITED] [LATEST Version]
  180. Trifluoperazine versus low-potency first-generation antipsychotic drugs for schizophrenia. PMID: 25003310 [NOT CITED] [LATEST Version]
  181. Trifluoperazine versus placebo for schizophrenia. PMID: 24414883 [NOT CITED] [LATEST Version]
  182. Twenty-four hour care for schizophrenia. PMID: 19370601 [NOT CITED] [LATEST Version]
  183. Valproate for schizophrenia. PMID: 27884042 [NOT CITED] [LATEST Version]
  184. Valproate for schizophrenia. PMID: 18646098 [NOT CITED] [OLD Version]
  185. Valproate for schizophrenia. PMID: 14974054 [NOT CITED] [OLD Version]
  186. Voxel-based morphometry for separation of schizophrenia from other types of psychosis in first episode psychosis. PMID: 26252640 [NOT CITED] [LATEST Version]
  187. Wendan decoction (Traditional Chinese medicine) for schizophrenia. PMID: 28657646 [NOT CITED] [LATEST Version]
  188. Yoga as part of a package of care versus non-standard care for schizophrenia. PMID: 30990224 [NOT CITED] [LATEST Version]
  189. Yoga as part of a package of care versus standard care for schizophrenia. PMID: 28960019 [NOT CITED] [LATEST Version]
  190. Yoga versus non-standard care for schizophrenia. PMID: 28956893 [NOT CITED] [LATEST Version]
  191. Yoga versus standard care for schizophrenia. PMID: 26488850 [NOT CITED] [LATEST Version]
  192. Ziprasidone versus other atypical antipsychotics for schizophrenia. PMID: 19821380 [NOT CITED] [LATEST Version]
  193. Zotepine for schizophrenia. PMID: 17054149 [NOT CITED] [LATEST Version]
  194. Zotepine versus other atypical antipsychotics for schizophrenia. PMID: 20927748 [NOT CITED] [LATEST Version]
  195. Zotepine versus other atypical antipsychotics for schizophrenia. PMID: 20091601 [NOT CITED] [OLD Version]
  196. Zuclopenthixol acetate for acute schizophrenia and similar serious mental illnesses. PMID: 22513898 [NOT CITED] [LATEST Version]
  197. Zuclopenthixol acetate for acute schizophrenia and similar serious mental illnesses. PMID: 15266432 [NOT CITED] [OLD Version]
  198. Zuclopenthixol dihydrochloride for schizophrenia. PMID: 29144549 [NOT CITED] [LATEST Version]
  199. Zuclopenthixol dihydrochloride for schizophrenia. PMID: 16235403 [NOT CITED] [OLD Version]
  200. Zuclopenthixol versus placebo for schizophrenia. PMID: 26624987 [NOT CITED] [LATEST Version]
1454 Q544006 anxiety disorder Anxiety disorder B 1-Top

Psychiatry
  1. Antidepressants for generalized anxiety disorder. PMID: 12804478 [NOT CITED] [LATEST Version]
  2. Antipsychotics for fibromyalgia in adults. PMID: 27251337 [NOT CITED] [LATEST Version]
  3. Atypical antipsychotics for disruptive behaviour disorders in children and youths. PMID: 22972123 [NOT CITED] [LATEST Version]
  4. Augmentation of cognitive and behavioural therapies (CBT) with d-cycloserine for anxiety and related disorders. PMID: 25957940 [NOT CITED] [LATEST Version]
  5. Azapirones for generalized anxiety disorder. PMID: 16856115 [NOT CITED] [LATEST Version]
  6. Azapirones versus placebo for panic disorder in adults. PMID: 25268297 [NOT CITED] [LATEST Version]
  7. Combined pharmacotherapy and psychological therapies for post traumatic stress disorder (PTSD). PMID: 20614457 [NOT CITED] [LATEST Version]
  8. Drug therapy for anxiety in palliative care. PMID: 14974072 [NOT CITED] [LATEST Version]
  9. Duloxetine versus other anti-depressive agents for depression. PMID: 23076926 [NOT CITED] [LATEST Version]
  10. Hydroxyzine for generalised anxiety disorder. PMID: 21154375 [NOT CITED] [LATEST Version]
  11. Morita therapy for anxiety disorders in adults. PMID: 25695214 [NOT CITED] [LATEST Version]
  12. Passiflora for anxiety disorder. PMID: 17253512 [NOT CITED] [LATEST Version]
  13. Pharmacotherapy augmentation strategies in treatment-resistant anxiety disorders. PMID: 17054260 [NOT CITED] [LATEST Version]
  14. Pharmacotherapy for anxiety and comorbid alcohol use disorders. PMID: 25601826 [NOT CITED] [LATEST Version]
  15. Pharmacotherapy for social anxiety disorder (SAnD). PMID: 29048739 [NOT CITED] [LATEST Version]
  16. Pharmacotherapy for social phobia. PMID: 15495010 [NOT CITED] [LATEST Version]
  17. Psychological therapies for generalised anxiety disorder. PMID: 17253466 [NOT CITED] [LATEST Version]
  18. Psychological treatment for anxiety in people with traumatic brain injury. PMID: 17636792 [NOT CITED] [LATEST Version]
  19. Psychological treatments versus treatment as usual for obsessive compulsive disorder (OCD). PMID: 17443583 [NOT CITED] [LATEST Version]
  20. Repetitive transcranial magnetic stimulation (rTMS) for panic disorder in adults. PMID: 25230088 [NOT CITED] [LATEST Version]
  21. Second-generation antipsychotics for anxiety disorders. PMID: 21154392 [NOT CITED] [LATEST Version]
  22. Therapeutic touch for anxiety disorders. PMID: 17636838 [NOT CITED] [LATEST Version]
  23. Therapist-supported Internet cognitive behavioural therapy for anxiety disorders in adults. PMID: 26968204 [CITED] [LATEST Version]
  24. Therapist-supported Internet cognitive behavioural therapy for anxiety disorders in adults. PMID: 25742186 [NOT CITED] [OLD Version]
  25. Valerian for anxiety disorders. PMID: 17054208 [NOT CITED] [LATEST Version]
260 Q131755 bipolar disorder Bipolar disorder B 1-Top

Neurology

Psychiatry
  1. Antiglucocorticoid treatments for mood disorders. PMID: 18254070 [NOT CITED] [LATEST Version]
  2. Aripiprazole alone or in combination for acute mania. PMID: 24346956 [NOT CITED] [LATEST Version]
  3. Azapirones versus placebo for panic disorder in adults. PMID: 25268297 [NOT CITED] [LATEST Version]
  4. Clotiapine for acute psychotic illnesses. PMID: 11279762 [NOT CITED] [LATEST Version]
  5. Collaborative care approaches for people with severe mental illness. PMID: 24190251 [NOT CITED] [LATEST Version]
  6. Compulsory community and involuntary outpatient treatment for people with severe mental disorders. PMID: 28303578 [NOT CITED] [LATEST Version]
  7. Compulsory community and involuntary outpatient treatment for people with severe mental disorders. PMID: 25474592 [NOT CITED] [OLD Version]
  8. Dietary supplements for preventing postnatal depression. PMID: 24158923 [NOT CITED] [LATEST Version]
  9. Droperidol for acute psychosis. PMID: 15495037 [NOT CITED] [LATEST Version]
  10. Droperidol for acute psychosis. PMID: 11406047 [NOT CITED] [OLD Version]
  11. Droperidol for psychosis-induced aggression or agitation. PMID: 27976370 [NOT CITED] [LATEST Version]
  12. Family interventions for bipolar disorder. PMID: 17943843 [NOT CITED] [LATEST Version]
  13. Haloperidol alone or in combination for acute mania. PMID: 16856043 [NOT CITED] [LATEST Version]
  14. Hemodialysis for lithium poisoning. PMID: 26374731 [NOT CITED] [LATEST Version]
  15. Interventions for helping people recognise early signs of recurrence in bipolar disorder. PMID: 17253526 [NOT CITED] [LATEST Version]
  16. Interventions to encourage uptake of cancer screening for people with severe mental illness. PMID: 27668891 [NOT CITED] [LATEST Version]
  17. Interventions to encourage uptake of cancer screening for people with severe mental illness. PMID: 23857563 [NOT CITED] [OLD Version]
  18. Ketamine and other glutamate receptor modulators for depression in bipolar disorder in adults. PMID: 26415966 [CITED] [LATEST Version]
  19. Lithium for acute mania. PMID: 31152444 [NOT CITED] [LATEST Version]
  20. Lithium for maintenance treatment of mood disorders. PMID: 11687035 [NOT CITED] [LATEST Version]
  21. Lithium for maintenance treatment of mood disorders. PMID: 11406061 [NOT CITED] [OLD Version]
  22. Olanzapine in long-term treatment for bipolar disorder. PMID: 19160237 [CITED] [LATEST Version]
  23. Omega-3 fatty acids for bipolar disorder. PMID: 18425912 [CITED] [LATEST Version]
  24. Oxcarbazepine for acute affective episodes in bipolar disorder. PMID: 22161387 [NOT CITED] [LATEST Version]
  25. Oxcarbazepine in the maintenance treatment of bipolar disorder. PMID: 18254071 [NOT CITED] [LATEST Version]
  26. Risperidone in long-term treatment for bipolar disorder. PMID: 17054229 [NOT CITED] [LATEST Version]
  27. Risperidone versus other antipsychotics for people with severe mental illness and co-occurring substance misuse. PMID: 29355909 [NOT CITED] [LATEST Version]
  28. Tiagabine for acute affective episodes in bipolar disorder. PMID: 23235614 [NOT CITED] [LATEST Version]
  29. Tiagabine in the maintenance treatment of bipolar disorder. PMID: 22161389 [NOT CITED] [LATEST Version]
  30. Tiagabine in the maintenance treatment of bipolar disorders. PMID: 16856081 [NOT CITED] [LATEST Version]
  31. Tiagabine in the treatment of acute affective episodes in bipolar disorder: efficacy and acceptability. PMID: 16856056 [NOT CITED] [LATEST Version]
  32. Topiramate for acute affective episodes in bipolar disorder in adults. PMID: 27591453 [NOT CITED] [LATEST Version]
  33. Topiramate for acute affective episodes in bipolar disorder. PMID: 16437453 [CITED] [LATEST Version]
  34. Valproate for acute mood episodes in bipolar disorder. PMID: 12535506 [CITED] [LATEST Version]
  35. Valproic acid, valproate and divalproex in the maintenance treatment of bipolar disorder. PMID: 24132760 [NOT CITED] [LATEST Version]
  36. Valproic acid, valproate and divalproex in the maintenance treatment of bipolar disorder. PMID: 11687047 [NOT CITED] [OLD Version]
4387 Q1060310 narcissistic personality disorder Narcissistic personality disorder B 2-High

Psychiatry

 No matching publication found!
4265 Q11072 amnesia Amnesia B 2-High

Psychiatry
  1. Midazolam for sedation before procedures. PMID: 27198122 [NOT CITED] [LATEST Version]
  2. Thiamine for Alzheimer's disease. PMID: 11405995 [NOT CITED] [LATEST Version]
  3. Thiamine for Alzheimer's disease. PMID: 10796655 [NOT CITED] [OLD Version]
4200 Q845224 generalized anxiety disorder Generalized anxiety disorder C 2-High

Psychiatry
  1. Antidepressants for generalized anxiety disorder. PMID: 12804478 [NOT CITED] [LATEST Version]
  2. Azapirones for generalized anxiety disorder. PMID: 16856115 [NOT CITED] [LATEST Version]
  3. Pharmacotherapy for anxiety and comorbid alcohol use disorders. PMID: 25601826 [NOT CITED] [LATEST Version]
  4. Therapist-supported Internet cognitive behavioural therapy for anxiety disorders in adults. PMID: 26968204 [NOT CITED] [LATEST Version]
  5. Therapist-supported Internet cognitive behavioural therapy for anxiety disorders in adults. PMID: 25742186 [NOT CITED] [OLD Version]
3960 Q935129 postpartum depression Postpartum depression C 2-High

Psychiatry
  1. Antidepressant prevention of postnatal depression. PMID: 15846711 [NOT CITED] [LATEST Version]
  2. Aspirin (single dose) for perineal pain in the early postpartum period. PMID: 28181214 [NOT CITED] [LATEST Version]
  3. Caregiver support for postpartum depression. PMID: 11686971 [NOT CITED] [LATEST Version]
  4. Caregiver support for postpartum depression. PMID: 10796226 [NOT CITED] [OLD Version]
  5. Continuous support for women during childbirth. PMID: 28681500 [NOT CITED] [LATEST Version]
  6. Dietary supplements for preventing postnatal depression. PMID: 24158923 [NOT CITED] [LATEST Version]
  7. Individual or group antenatal education for childbirth or parenthood, or both. PMID: 17636711 [NOT CITED] [LATEST Version]
  8. Oestrogens and progestins for preventing and treating postpartum depression. PMID: 18843619 [NOT CITED] [LATEST Version]
  9. Oestrogens and progestogens for preventing and treating postnatal depression. PMID: 10796270 [NOT CITED] [LATEST Version]
  10. Oral non-steroidal anti-inflammatory drugs (single dose) for perineal pain in the early postpartum period. PMID: 27412362 [NOT CITED] [LATEST Version]
  11. Parent-infant psychotherapy for improving parental and infant mental health. PMID: 25569177 [NOT CITED] [LATEST Version]
  12. Psychosocial and psychological interventions for preventing postpartum depression. PMID: 23450532 [CITED] [LATEST Version]
  13. Psychosocial and psychological interventions for preventing postpartum depression. PMID: 15495008 [NOT CITED] [OLD Version]
  14. Psychosocial and psychological interventions for treating postpartum depression. PMID: 17943888 [CITED] [LATEST Version]
  15. Supplementation with long chain polyunsaturated fatty acids (LCPUFA) to breastfeeding mothers for improving child growth and development. PMID: 26171898 [NOT CITED] [LATEST Version]
  16. Supplementation with long chain polyunsaturated fatty acids (LCPUFA) to breastfeeding mothers for improving child growth and development. PMID: 21154388 [NOT CITED] [OLD Version]
  17. The impact of surgical therapies for inflammatory bowel disease on female fertility. PMID: 31334846 [NOT CITED] [LATEST Version]
3551 Q7632070 substance use disorder Substance use disorder C 2-High

Psychiatry
  1. Pharmacological therapies for maintenance treatments of opium dependence. PMID: 23440817 [NOT CITED] [LATEST Version]
  2. Psychological therapies for post-traumatic stress disorder and comorbid substance use disorder. PMID: 27040448 [NOT CITED] [LATEST Version]
  3. Psychological therapies versus antidepressant medication, alone and in combination for depression in children and adolescents. PMID: 25433518 [NOT CITED] [LATEST Version]
  4. Psychological therapies versus antidepressant medication, alone and in combination for depression in children and adolescents. PMID: 23152255 [NOT CITED] [OLD Version]
  5. Psychosocial interventions for cannabis use disorder. PMID: 27149547 [NOT CITED] [LATEST Version]
  6. Psychotherapeutic interventions for cannabis abuse and/or dependence in outpatient settings. PMID: 16856093 [NOT CITED] [LATEST Version]
3325 Q1639178 opioid abuse Opioid use disorder C 2-High

Psychiatry
  1. Psychosocial treatment for opiate abuse and dependence. PMID: 15744796 [NOT CITED] [LATEST Version]
61 Q170082 psychosis Psychosis B 2-High

Psychiatry
  1. Antidepressants for agitation and psychosis in dementia. PMID: 21328305 [NOT CITED] [LATEST Version]
  2. Antidepressants for people with both schizophrenia and depression. PMID: 12076447 [NOT CITED] [LATEST Version]
  3. Antiglucocorticoid and related treatments for psychosis. PMID: 26725721 [NOT CITED] [LATEST Version]
  4. Antipsychotic drug treatment for elderly people with late-onset schizophrenia. PMID: 12804499 [NOT CITED] [LATEST Version]
  5. Antipsychotic drugs for non-affective psychosis during pregnancy and postpartum. PMID: 15106251 [NOT CITED] [LATEST Version]
  6. Antipsychotic medication for childhood-onset schizophrenia. PMID: 17636744 [NOT CITED] [LATEST Version]
  7. Aripiprazole (intramuscular) for psychosis-induced aggression or agitation (rapid tranquillisation). PMID: 29308601 [NOT CITED] [LATEST Version]
  8. Aripiprazole versus placebo for schizophrenia. PMID: 21833956 [NOT CITED] [LATEST Version]
  9. Aripiprazole versus typical antipsychotic drugs for schizophrenia. PMID: 18646161 [NOT CITED] [LATEST Version]
  10. Aripiprazole versus typicals for schizophrenia. PMID: 18254107 [NOT CITED] [LATEST Version]
  11. Atypical antipsychotics for psychosis in adolescents. PMID: 24129841 [NOT CITED] [LATEST Version]
  12. Benzodiazepines alone or in combination with antipsychotic drugs for acute psychosis. PMID: 16235313 [NOT CITED] [LATEST Version]
  13. Benzodiazepines for psychosis-induced aggression or agitation. PMID: 29219171 [NOT CITED] [LATEST Version]
  14. Benzodiazepines for psychosis-induced aggression or agitation. PMID: 24049046 [NOT CITED] [OLD Version]
  15. Benzodiazepines for psychosis-induced aggression or agitation. PMID: 23633309 [NOT CITED] [OLD Version]
  16. Benzodiazepines for schizophrenia. PMID: 23152236 [NOT CITED] [LATEST Version]
  17. Cannabis and schizophrenia. PMID: 25314586 [NOT CITED] [LATEST Version]
  18. Cannabis and schizophrenia. PMID: 18646115 [NOT CITED] [OLD Version]
  19. Chlorpromazine for psychosis induced aggression or agitation. PMID: 20393959 [NOT CITED] [LATEST Version]
  20. Clotiapine for acute psychotic illnesses. PMID: 11279762 [NOT CITED] [LATEST Version]
  21. Clozapine for psychotic disorders in adults with intellectual disabilities. PMID: 26397173 [NOT CITED] [LATEST Version]
  22. Cognitive behavioural therapy (brief versus standard duration) for schizophrenia. PMID: 26488686 [NOT CITED] [LATEST Version]
  23. Cognitive behavioural therapy (brief versus standard duration) for schizophrenia. PMID: 24723312 [NOT CITED] [OLD Version]
  24. Collaborative care approaches for people with severe mental illness. PMID: 24190251 [NOT CITED] [LATEST Version]
  25. Cyclophosphamide versus methylprednisolone for the treatment of neuropsychiatric involvement in systemic lupus erythematosus. PMID: 10908541 [NOT CITED] [LATEST Version]
  26. Cyclophosphamide versus methylprednisolone for treating neuropsychiatric involvement in systemic lupus erythematosus. PMID: 16625558 [NOT CITED] [LATEST Version]
  27. De-escalation techniques for managing non-psychosis induced aggression in adults. PMID: 30019748 [NOT CITED] [LATEST Version]
  28. De-escalation techniques for psychosis-induced aggression or agitation. PMID: 28368091 [NOT CITED] [LATEST Version]
  29. Depot risperidone for schizophrenia. PMID: 14584007 [NOT CITED] [LATEST Version]
  30. Dietary advice for people with schizophrenia. PMID: 27007216 [NOT CITED] [LATEST Version]
  31. Droperidol for acute psychosis. PMID: 15495037 [NOT CITED] [LATEST Version]
  32. Droperidol for acute psychosis. PMID: 11406047 [NOT CITED] [OLD Version]
  33. Droperidol for psychosis-induced aggression or agitation. PMID: 27976370 [NOT CITED] [LATEST Version]
  34. Early intervention for psychosis. PMID: 21678345 [CITED] [LATEST Version]
  35. Early intervention for psychosis. PMID: 17054213 [NOT CITED] [OLD Version]
  36. Early Intervention for psychosis. PMID: 15106257 [NOT CITED] [OLD Version]
  37. Educational games for mental health professionals. PMID: 16625545 [NOT CITED] [LATEST Version]
  38. Estrogen for schizophrenia. PMID: 16235377 [NOT CITED] [LATEST Version]
  39. First rank symptoms for schizophrenia. PMID: 25879096 [NOT CITED] [LATEST Version]
  40. Flupenthixol versus low-potency first-generation antipsychotic drugs for schizophrenia. PMID: 25177834 [NOT CITED] [LATEST Version]
  41. Fluphenazine versus low-potency first-generation antipsychotic drugs for schizophrenia. PMID: 25087165 [NOT CITED] [LATEST Version]
  42. Haloperidol for long-term aggression in psychosis. PMID: 27889922 [NOT CITED] [LATEST Version]
  43. Haloperidol for psychosis-induced aggression or agitation (rapid tranquillisation). PMID: 28758203 [NOT CITED] [LATEST Version]
  44. Haloperidol for psychosis-induced aggression or agitation (rapid tranquillisation). PMID: 23152276 [NOT CITED] [OLD Version]
  45. Haloperidol plus promethazine for psychosis induced aggression. PMID: 15654706 [NOT CITED] [LATEST Version]
  46. Haloperidol plus promethazine for psychosis-induced aggression. PMID: 27885664 [NOT CITED] [LATEST Version]
  47. Haloperidol plus promethazine for psychosis-induced aggression. PMID: 19588366 [NOT CITED] [OLD Version]
  48. Haloperidol versus first-generation antipsychotics for the treatment of schizophrenia and other psychotic disorders. PMID: 25592299 [NOT CITED] [LATEST Version]
  49. Haloperidol versus low-potency first-generation antipsychotic drugs for schizophrenia. PMID: 25007358 [NOT CITED] [LATEST Version]
  50. Information and communication technology in patient education and support for people with schizophrenia. PMID: 23076932 [NOT CITED] [LATEST Version]
  51. Interventions for psychotic symptoms concomitant with epilepsy. PMID: 26690687 [NOT CITED] [LATEST Version]
  52. Interventions for psychotic symptoms concomitant with epilepsy. PMID: 18843704 [NOT CITED] [OLD Version]
  53. Olanzapine versus other atypical antipsychotics for schizophrenia. PMID: 20238348 [NOT CITED] [LATEST Version]
  54. Open general medical wards versus specialist psychiatric units for acute psychoses. PMID: 17943786 [NOT CITED] [LATEST Version]
  55. Open general medical wards versus specialist psychiatric units for acute psychoses. PMID: 12804459 [NOT CITED] [OLD Version]
  56. Paliperidone for schizophrenia. PMID: 18425951 [NOT CITED] [LATEST Version]
  57. Paliperidone palmitate for schizophrenia. PMID: 22696377 [NOT CITED] [LATEST Version]
  58. Pharmacological treatment for psychotic depression. PMID: 26225902 [NOT CITED] [LATEST Version]
  59. Pharmacological treatment for psychotic depression. PMID: 24282034 [NOT CITED] [OLD Version]
  60. Pharmacological treatments for psychosis-related polydipsia. PMID: 17054176 [NOT CITED] [LATEST Version]
  61. Pharmacological treatments for psychosis-related polydipsia. PMID: 12137700 [NOT CITED] [OLD Version]
  62. Preventive interventions for postnatal psychosis. PMID: 23740790 [NOT CITED] [LATEST Version]
  63. Psychoeducation for siblings of people with severe mental illness. PMID: 25953641 [NOT CITED] [LATEST Version]
  64. Psychological interventions for post-traumatic stress disorder (PTSD) in people with severe mental illness. PMID: 28116752 [NOT CITED] [LATEST Version]
  65. Quetiapine versus other atypical antipsychotics for schizophrenia. PMID: 20091600 [NOT CITED] [LATEST Version]
  66. Quetiapine versus typical antipsychotic medications for schizophrenia. PMID: 23728667 [NOT CITED] [LATEST Version]
  67. Risperidone for psychosis-induced aggression or agitation (rapid tranquillisation). PMID: 29634083 [NOT CITED] [LATEST Version]
  68. Risperidone versus other atypical antipsychotics for schizophrenia. PMID: 21249678 [NOT CITED] [LATEST Version]
  69. Sertindole for schizophrenia. PMID: 16034864 [NOT CITED] [LATEST Version]
  70. Sertindole versus other atypical antipsychotics for schizophrenia. PMID: 19370652 [NOT CITED] [LATEST Version]
  71. The effectiveness of atypical antipsychotics for the treatment of aggression and psychosis in Alzheimer's disease. PMID: 16437455 [NOT CITED] [LATEST Version]
  72. Therapeutic interventions for symptomatic treatment in Huntington's disease. PMID: 19588393 [NOT CITED] [LATEST Version]
  73. Training to recognise the early signs of recurrence in schizophrenia. PMID: 23450559 [NOT CITED] [LATEST Version]
  74. Treatment for amphetamine psychosis. PMID: 19160215 [NOT CITED] [LATEST Version]
  75. Treatment for amphetamine psychosis. PMID: 18843639 [NOT CITED] [OLD Version]
  76. Treatment for amphetamine psychosis. PMID: 11687172 [NOT CITED] [OLD Version]
  77. Treatment of Lennox-Gastaut syndrome. PMID: 23450537 [NOT CITED] [LATEST Version]
  78. Treatment of Lennox-Gastaut syndrome. PMID: 19588340 [NOT CITED] [OLD Version]
  79. Treatment of Lennox-Gastaut syndrome. PMID: 12917958 [NOT CITED] [OLD Version]
  80. Trifluoperazine versus low-potency first-generation antipsychotic drugs for schizophrenia. PMID: 25003310 [NOT CITED] [LATEST Version]
  81. Tripterygium wilfordii Hook F (a traditional Chinese medicine) for primary nephrotic syndrome. PMID: 23934958 [NOT CITED] [LATEST Version]
  82. Valproic acid, valproate and divalproex in the maintenance treatment of bipolar disorder. PMID: 11687047 [NOT CITED] [LATEST Version]
  83. Voxel-based morphometry for separation of schizophrenia from other types of psychosis in first episode psychosis. PMID: 26252640 [NOT CITED] [LATEST Version]
  84. Withdrawal versus continuation of chronic antipsychotic drugs for behavioural and psychological symptoms in older people with dementia. PMID: 23543555 [NOT CITED] [LATEST Version]
  85. Withdrawal versus continuation of long-term antipsychotic drug use for behavioural and psychological symptoms in older people with dementia. PMID: 29605970 [NOT CITED] [LATEST Version]
  86. Zuclopenthixol acetate for acute schizophrenia and similar serious mental illnesses. PMID: 22513898 [NOT CITED] [LATEST Version]
  87. Zuclopenthixol acetate for acute schizophrenia and similar serious mental illnesses. PMID: 15266432 [NOT CITED] [OLD Version]
156 Q208166 borderline personality disorder Borderline personality disorder B 2-High

Psychiatry
  1. Antiepileptics for aggression and associated impulsivity. PMID: 20166067 [NOT CITED] [LATEST Version]
  2. Crisis interventions for people with borderline personality disorder. PMID: 22696385 [NOT CITED] [LATEST Version]
  3. Pharmacological interventions for borderline personality disorder. PMID: 20556762 [CITED] [LATEST Version]
  4. Pharmacological interventions for people with borderline personality disorder. PMID: 16437535 [NOT CITED] [LATEST Version]
  5. Psychological therapies for people with borderline personality disorder. PMID: 22895952 [CITED] [LATEST Version]
  6. Psychological therapies for people with borderline personality disorder. PMID: 16437534 [NOT CITED] [OLD Version]
163 Q209647 delirium tremens Delirium tremens B 2-High

Neurology

Psychiatry
  1. Magnesium for alcohol withdrawal. PMID: 23740536 [NOT CITED] [LATEST Version]
259 Q131749 anorexia nervosa Anorexia nervosa B 2-High

Psychiatry
  1. Antidepressants for anorexia nervosa. PMID: 16437485 [NOT CITED] [LATEST Version]
  2. Bisphosphonate therapy for children and adolescents with secondary osteoporosis. PMID: 17943849 [NOT CITED] [LATEST Version]
  3. Family therapy approaches for anorexia nervosa. PMID: 31041816 [CITED] [LATEST Version]
  4. Family therapy approaches for anorexia nervosa. PMID: 30320438 [NOT CITED] [OLD Version]
  5. Family therapy for anorexia nervosa. PMID: 20393940 [NOT CITED] [LATEST Version]
  6. Individual psychological therapy in the outpatient treatment of adults with anorexia nervosa. PMID: 26212713 [NOT CITED] [LATEST Version]
  7. Individual psychotherapy in the outpatient treatment of adults with anorexia nervosa. PMID: 14583998 [NOT CITED] [LATEST Version]
  8. Inpatient versus outpatient care, partial hospitalisation and waiting list for people with eating disorders. PMID: 30663033 [NOT CITED] [LATEST Version]
  9. Self-help and guided self-help for eating disorders. PMID: 16856036 [NOT CITED] [LATEST Version]
3533 Q4915474 bipolar I disorder Bipolar I disorder C 3-Mid

Psychiatry

 No matching publication found!
195 Q317158 adjustment disorder Adjustment disorder C 3-Mid

Psychiatry
  1. Antidepressants for depression in physically ill people. PMID: 20238354 [NOT CITED] [LATEST Version]
  2. Antidepressants for the treatment of depression in people with cancer. PMID: 29683474 [NOT CITED] [LATEST Version]
  3. Antidepressants for the treatment of depression in people with cancer. PMID: 26029972 [NOT CITED] [OLD Version]
  4. Interventions to facilitate return to work in adults with adjustment disorders. PMID: 23235630 [NOT CITED] [LATEST Version]
3576 Q845787 histrionic personality disorder Histrionic personality disorder C 3-Mid

Psychiatry

 No matching publication found!
3812 Q2151786 substance-induced psychosis Substance-induced psychosis C 3-Mid

Psychiatry

 No matching publication found!
3882 Q912344 ego-dystonic sexual orientation Ego-dystonic sexual orientation Start 3-Mid

Psychiatry

 No matching publication found!
3957 Q28823477 passive–aggressive personality disorder Passive–aggressive personality disorder C 3-Mid

Psychiatry

 No matching publication found!
166 Q303555 hypoactive sexual desire disorder Hypoactive sexual desire disorder C 3-Mid

Psychiatry

 No matching publication found!
4198 Q844590 body dysmorphic disorder Body dysmorphic disorder C 3-Mid

Dermatology

Psychiatry
  1. Pharmacotherapy and psychotherapy for body dysmorphic disorder. PMID: 19160252 [NOT CITED] [LATEST Version]
4262 Q8388 pedophilia Pedophilia B 3-Mid

Psychiatry

 No matching publication found!
422 Q498237 schizoid personality disorder Schizoid personality disorder B 3-Mid

Psychiatry

 No matching publication found!
140 Q373822 eating disorder Eating disorder C 3-Mid

Psychiatry
  1. Antidepressants for anorexia nervosa. PMID: 16437485 [NOT CITED] [LATEST Version]
  2. Family therapy approaches for anorexia nervosa. PMID: 31041816 [NOT CITED] [LATEST Version]
  3. Family therapy approaches for anorexia nervosa. PMID: 30320438 [NOT CITED] [OLD Version]
  4. Individual psychological therapy in the outpatient treatment of adults with anorexia nervosa. PMID: 26212713 [NOT CITED] [LATEST Version]
  5. Individual psychotherapy in the outpatient treatment of adults with anorexia nervosa. PMID: 14583998 [NOT CITED] [LATEST Version]
  6. Inpatient versus outpatient care, partial hospitalisation and waiting list for people with eating disorders. PMID: 30663033 [NOT CITED] [LATEST Version]
  7. Interventions for preventing eating disorders in children and adolescents. PMID: 12076457 [NOT CITED] [LATEST Version]
  8. Psychological treatments for bulimia nervosa and binging. PMID: 19821271 [NOT CITED] [LATEST Version]
  9. Psychotherapy for bulimia nervosa and binging. PMID: 15266434 [NOT CITED] [LATEST Version]
  10. Psychotherapy for bulimia nervosa and binging. PMID: 12535397 [NOT CITED] [OLD Version]
  11. Psychotherapy for bulimia nervosa and binging. PMID: 11686968 [NOT CITED] [OLD Version]
  12. Psychotherapy for bulimia nervosa and binging. PMID: 11034689 [NOT CITED] [OLD Version]
  13. Psychotherapy for bulimia nervosa and binging. PMID: 10796725 [NOT CITED] [OLD Version]
  14. Self-help and guided self-help for eating disorders. PMID: 16856036 [CITED] [LATEST Version]
128 Q174589 agoraphobia Agoraphobia B 3-Mid

Psychiatry
  1. Antidepressants versus placebo for panic disorder in adults. PMID: 29620793 [NOT CITED] [LATEST Version]
  2. Augmentation of cognitive and behavioural therapies (CBT) with d-cycloserine for anxiety and related disorders. PMID: 25957940 [NOT CITED] [LATEST Version]
  3. Azapirones versus placebo for panic disorder in adults. PMID: 25268297 [NOT CITED] [LATEST Version]
  4. Benzodiazepines versus placebo for panic disorder in adults. PMID: 30921478 [NOT CITED] [LATEST Version]
  5. Combined psychotherapy plus antidepressants for panic disorder with or without agoraphobia. PMID: 17253502 [NOT CITED] [LATEST Version]
  6. Passiflora for anxiety disorder. PMID: 17253512 [NOT CITED] [LATEST Version]
  7. Psychological therapies for panic disorder with or without agoraphobia in adults: a network meta-analysis. PMID: 27071857 [CITED] [LATEST Version]
  8. Psychological therapies versus pharmacological interventions for panic disorder with or without agoraphobia in adults. PMID: 27730622 [NOT CITED] [LATEST Version]
  9. Therapist-supported Internet cognitive behavioural therapy for anxiety disorders in adults. PMID: 26968204 [NOT CITED] [LATEST Version]
  10. Therapist-supported Internet cognitive behavioural therapy for anxiety disorders in adults. PMID: 25742186 [NOT CITED] [OLD Version]
  11. Valerian for anxiety disorders. PMID: 17054208 [NOT CITED] [LATEST Version]
4329 Q1049021 gender dysphoria Gender dysphoria C 3-Mid

Psychiatry

 No matching publication found!
4395 Q2580627 Masked depression Masked depression Start 3-Mid

Psychiatry

 No matching publication found!
4397 Q2583311 tabes dorsalis Tabes dorsalis Start 3-Mid

Neurology

Psychiatry

 No matching publication found!
74 Q270673 personality disorder Personality disorder C 3-Mid

Psychiatry
  1. Antiepileptics for aggression and associated impulsivity. PMID: 20166067 [NOT CITED] [LATEST Version]
  2. Crisis interventions for people with borderline personality disorder. PMID: 22696385 [NOT CITED] [LATEST Version]
  3. Pharmacological interventions for antisocial personality disorder. PMID: 20687091 [NOT CITED] [LATEST Version]
  4. Pharmacological interventions for borderline personality disorder. PMID: 20556762 [NOT CITED] [LATEST Version]
  5. Pharmacological interventions for obsessive-compulsive personality disorder. PMID: 25267900 [NOT CITED] [LATEST Version]
  6. Pharmacological interventions for paranoid personality disorder. PMID: 25267902 [NOT CITED] [LATEST Version]
  7. Pharmacological interventions for people with borderline personality disorder. PMID: 16437535 [NOT CITED] [LATEST Version]
  8. Pharmacological interventions for schizotypal personality disorder. PMID: 25267897 [NOT CITED] [LATEST Version]
  9. Psychological interventions for antisocial personality disorder. PMID: 20556783 [NOT CITED] [LATEST Version]
  10. Psychological interventions for obsessive-compulsive personality disorder. PMID: 25267901 [NOT CITED] [LATEST Version]
  11. Psychological therapies for people with borderline personality disorder. PMID: 22895952 [NOT CITED] [LATEST Version]
  12. Psychological therapies for people with borderline personality disorder. PMID: 16437534 [NOT CITED] [OLD Version]
  13. Psychosocial interventions for self-harm in adults. PMID: 27168519 [NOT CITED] [LATEST Version]
  14. Short-term psychodynamic psychotherapies for common mental disorders. PMID: 24984083 [NOT CITED] [LATEST Version]
4437 Q2627467 dissociative disorder Dissociative disorder C 3-Mid

Psychiatry

 No matching publication found!
4445 Q2657784 atypical depressive disorder Atypical depression Start 3-Mid

Psychiatry

 No matching publication found!
4527 Q18657 dissociative identity disorder Dissociative identity disorder B 3-Mid

Psychiatry

 No matching publication found!
4528 Q18671 intermittent explosive disorder Intermittent explosive disorder C 3-Mid

Psychiatry

 No matching publication found!
4575 Q1142806 developmental disability Developmental disability B 3-Mid

Psychiatry
  1. Prophylactic methylxanthine for prevention of apnoea in preterm infants. PMID: 21154344 [NOT CITED] [LATEST Version]
3299 Q1578799 trichophagia Trichophagia Start 3-Mid

Psychiatry

 No matching publication found!
3268 Q13512178 melancholia Melancholic depression Start 3-Mid

Psychiatry

 No matching publication found!
231 Q427810 dysthymic disorder Dysthymia B 3-Mid

Psychiatry
  1. Acupuncture for depression. PMID: 20091556 [NOT CITED] [LATEST Version]
  2. Acupuncture for depression. PMID: 15846693 [NOT CITED] [OLD Version]
  3. Antidepressants for the treatment of depression in people with cancer. PMID: 29683474 [NOT CITED] [LATEST Version]
  4. Antidepressants for the treatment of depression in people with cancer. PMID: 26029972 [NOT CITED] [OLD Version]
  5. Interventions for preventing relapse and recurrence of a depressive disorder in children and adolescents. PMID: 23152246 [NOT CITED] [LATEST Version]
1425 Q509122 avoidant personality disorder Avoidant personality disorder C 3-Mid

Psychiatry

 No matching publication found!
469 Q188611 hypomania Hypomania C 3-Mid

Psychiatry
  1. Light therapy for non-seasonal depression. PMID: 15106233 [NOT CITED] [LATEST Version]
  2. Oxcarbazepine for acute affective episodes in bipolar disorder. PMID: 22161387 [NOT CITED] [LATEST Version]
  3. S-adenosyl methionine (SAMe) for depression in adults. PMID: 27727432 [NOT CITED] [LATEST Version]
470 Q188638 mood disorder Mood disorder C 3-Mid

Psychiatry
  1. Alternating current cranial electrotherapy stimulation (CES) for depression. PMID: 25000907 [NOT CITED] [LATEST Version]
  2. Antidepressants for polycystic ovary syndrome. PMID: 23728677 [NOT CITED] [LATEST Version]
  3. Lithium for maintenance treatment of mood disorders. PMID: 11687035 [NOT CITED] [LATEST Version]
  4. Lithium for maintenance treatment of mood disorders. PMID: 11406061 [NOT CITED] [OLD Version]
  5. Lithium versus antidepressants in the long-term treatment of unipolar affective disorder. PMID: 17054174 [NOT CITED] [LATEST Version]
  6. Music therapy for depression. PMID: 29144545 [NOT CITED] [LATEST Version]
  7. Risperidone in long-term treatment for bipolar disorder. PMID: 17054229 [NOT CITED] [LATEST Version]
  8. Tiagabine in the treatment of acute affective episodes in bipolar disorder: efficacy and acceptability. PMID: 16856056 [NOT CITED] [LATEST Version]
  9. Topiramate for acute affective episodes in bipolar disorder. PMID: 16437453 [NOT CITED] [LATEST Version]
  10. Valproic acid, valproate and divalproex in the maintenance treatment of bipolar disorder. PMID: 11687047 [NOT CITED] [LATEST Version]
761 Q1374020 somatization disorder Somatization disorder Start 3-Mid

Psychiatry

 No matching publication found!
907 Q567869 anosognosia Anosognosia C 3-Mid

Neurology

Psychiatry

 No matching publication found!
1110 Q596474 conduct disorder Conduct disorder C 3-Mid

Psychiatry
  1. Antiepileptics for aggression and associated impulsivity. PMID: 20166067 [NOT CITED] [LATEST Version]
  2. Atypical antipsychotics for disruptive behaviour disorders in children and youths. PMID: 22972123 [NOT CITED] [LATEST Version]
  3. Family and parenting interventions in children and adolescents with conduct disorder and delinquency aged 10-17. PMID: 11406062 [NOT CITED] [LATEST Version]
1412 Q191779 Gilles de la Tourette syndrome Tourette syndrome FA 3-Mid

Medical genetics

Neurology

Psychiatry
  1. Botulinum toxin for motor and phonic tics in Tourette's syndrome. PMID: 29304272 [NOT CITED] [LATEST Version]
  2. Cannabinoids for Tourette's Syndrome. PMID: 19821373 [NOT CITED] [LATEST Version]
3221 Q7256482 psychosexual disorder Psychosexual disorder C 3-Mid

Psychiatry

 No matching publication found!
1436 Q2855814 simple-type schizophrenia Simple-type schizophrenia C 3-Mid

Psychiatry

 No matching publication found!
1499 Q3184856 substance abuse Substance abuse B 3-Mid

Psychiatry
  1. A comparison of active drugs for the treatment of dysthymia. PMID: 12918001 [NOT CITED] [LATEST Version]
  2. A comparison of drugs versus placebo for the treatment of dysthymia. PMID: 10796749 [NOT CITED] [LATEST Version]
  3. Brief school-based interventions and behavioural outcomes for substance-using adolescents. PMID: 26787125 [CITED] [LATEST Version]
  4. Cannabis-based medicines for chronic neuropathic pain in adults. PMID: 29513392 [NOT CITED] [LATEST Version]
  5. Clotiapine for acute psychotic illnesses. PMID: 11279762 [NOT CITED] [LATEST Version]
  6. Cognitive behavioural therapy for anxiety disorders in children and adolescents. PMID: 16235374 [NOT CITED] [LATEST Version]
  7. Cognitive behavioural therapy for men who physically abuse their female partner. PMID: 17636823 [NOT CITED] [LATEST Version]
  8. Day hospital versus admission for acute psychiatric disorders. PMID: 22161384 [NOT CITED] [LATEST Version]
  9. Day hospital versus admission for acute psychiatric disorders. PMID: 12535505 [NOT CITED] [OLD Version]
  10. Day hospital versus out-patient care for psychiatric disorders. PMID: 11687059 [NOT CITED] [LATEST Version]
  11. Dietary supplements for preventing postnatal depression. PMID: 24158923 [NOT CITED] [LATEST Version]
  12. Drugs versus placebo for dysthymia. PMID: 11034701 [NOT CITED] [LATEST Version]
  13. Interactive telemedicine: effects on professional practice and health care outcomes. PMID: 26343551 [NOT CITED] [LATEST Version]
  14. Interventions for pathological gambling. PMID: 10796802 [NOT CITED] [LATEST Version]
  15. Interventions for smoking cessation in hospitalised patients. PMID: 22592676 [NOT CITED] [LATEST Version]
  16. Interventions for smoking cessation in hospitalised patients. PMID: 17636688 [NOT CITED] [OLD Version]
  17. Interventions for smoking cessation in hospitalised patients. PMID: 12535418 [NOT CITED] [OLD Version]
  18. Interventions for smoking cessation in hospitalised patients. PMID: 11406012 [NOT CITED] [OLD Version]
  19. Managed alcohol as a harm reduction intervention for alcohol addiction in populations at high risk for substance abuse. PMID: 23235633 [NOT CITED] [LATEST Version]
  20. Motivational interviewing for improving outcomes in youth living with HIV. PMID: 22972147 [NOT CITED] [LATEST Version]
  21. Motivational interviewing for substance abuse. PMID: 21563163 [NOT CITED] [LATEST Version]
  22. Non-specialist health worker interventions for the care of mental, neurological and substance-abuse disorders in low- and middle-income countries. PMID: 24249541 [NOT CITED] [LATEST Version]
  23. Preconception lifestyle advice for people with subfertility. PMID: 20393968 [NOT CITED] [LATEST Version]
  24. Psychological and/or educational interventions for the prevention of depression in children and adolescents. PMID: 14974014 [NOT CITED] [LATEST Version]
  25. Psychological therapies for people with borderline personality disorder. PMID: 16437534 [NOT CITED] [LATEST Version]
  26. Psychosocial interventions to reduce alcohol consumption in concurrent problem alcohol and illicit drug users. PMID: 30521696 [NOT CITED] [LATEST Version]
  27. Risperidone versus other antipsychotics for people with severe mental illness and co-occurring substance misuse. PMID: 29355909 [NOT CITED] [LATEST Version]
  28. Treatment for inhalant dependence and abuse. PMID: 21154379 [NOT CITED] [LATEST Version]
  29. Treatment for methaqualone dependence in adults. PMID: 15846700 [NOT CITED] [LATEST Version]
2335 Q4086956 bipolar ll disorder Bipolar II disorder Start 3-Mid

Psychiatry

 No matching publication found!
1563 Q629515 stimulant psychosis Stimulant psychosis C 3-Mid

Psychiatry

 No matching publication found!
3052 Q834047 schizoaffective disorder Schizoaffective disorder C 3-Mid

Psychiatry
  1. Antidepressants for people with both schizophrenia and depression. PMID: 12076447 [NOT CITED] [LATEST Version]
  2. Antiglucocorticoid and related treatments for psychosis. PMID: 26725721 [NOT CITED] [LATEST Version]
  3. Antipsychotic drug treatment for elderly people with late-onset schizophrenia. PMID: 12804499 [NOT CITED] [LATEST Version]
  4. Asenapine versus placebo for schizophrenia. PMID: 26599405 [NOT CITED] [LATEST Version]
  5. Atypical antipsychotics for psychosis in adolescents. PMID: 24129841 [NOT CITED] [LATEST Version]
  6. Benzodiazepines for antipsychotic-induced tardive dyskinesia. PMID: 29352477 [NOT CITED] [LATEST Version]
  7. Calcium channel blockers for antipsychotic-induced tardive dyskinesia. PMID: 29578611 [NOT CITED] [LATEST Version]
  8. Calcium channel blockers for neuroleptic-induced tardive dyskinesia. PMID: 22071797 [NOT CITED] [LATEST Version]
  9. Calcium channel blockers for neuroleptic-induced tardive dyskinesia. PMID: 14973950 [NOT CITED] [OLD Version]
  10. Calcium channel blockers for neuroleptic-induced tardive dyskinesia. PMID: 11279683 [NOT CITED] [OLD Version]
  11. Carbamazepine for schizophrenia and schizoaffective psychoses. PMID: 12137621 [NOT CITED] [LATEST Version]
  12. Carbamazepine for schizophrenia. PMID: 24789267 [NOT CITED] [LATEST Version]
  13. Carbamazepine for schizophrenia. PMID: 17636660 [NOT CITED] [OLD Version]
  14. Clotiapine for acute psychotic illnesses. PMID: 11279762 [NOT CITED] [LATEST Version]
  15. Clozapine dose for schizophrenia. PMID: 28613395 [NOT CITED] [LATEST Version]
  16. Communication skills training for mental health professionals working with people with severe mental illness. PMID: 28613384 [NOT CITED] [LATEST Version]
  17. Different communication strategies for disclosing a diagnosis of schizophrenia and related disorders. PMID: 29064090 [NOT CITED] [LATEST Version]
  18. Droperidol for acute psychosis. PMID: 15495037 [NOT CITED] [LATEST Version]
  19. Droperidol for acute psychosis. PMID: 11406047 [NOT CITED] [OLD Version]
  20. Droperidol for psychosis-induced aggression or agitation. PMID: 27976370 [NOT CITED] [LATEST Version]
  21. Electroconvulsive therapy for schizophrenia. PMID: 15846598 [NOT CITED] [LATEST Version]
  22. Electroconvulsive therapy for schizophrenia. PMID: 12076380 [NOT CITED] [OLD Version]
  23. Electroconvulsive therapy for schizophrenia. PMID: 10796292 [NOT CITED] [OLD Version]
  24. Family intervention (brief) for schizophrenia. PMID: 24595545 [NOT CITED] [LATEST Version]
  25. Family intervention for schizophrenia. PMID: 21154340 [NOT CITED] [LATEST Version]
  26. Family intervention for schizophrenia. PMID: 17054127 [NOT CITED] [OLD Version]
  27. Family intervention for schizophrenia. PMID: 14583908 [NOT CITED] [OLD Version]
  28. Family intervention for schizophrenia. PMID: 10796294 [NOT CITED] [OLD Version]
  29. Gamma-aminobutyric acid agonists for antipsychotic-induced tardive dyskinesia. PMID: 29663328 [NOT CITED] [LATEST Version]
  30. Haloperidol alone or in combination for acute mania. PMID: 16856043 [NOT CITED] [LATEST Version]
  31. Interventions for smoking cessation and reduction in individuals with schizophrenia. PMID: 23450574 [NOT CITED] [LATEST Version]
  32. Interventions for smoking cessation and reduction in individuals with schizophrenia. PMID: 20556777 [NOT CITED] [OLD Version]
  33. Selective noradrenaline reuptake inhibitors for schizophrenia. PMID: 29368813 [NOT CITED] [LATEST Version]
  34. Self management interventions for type 2 diabetes in adult people with severe mental illness. PMID: 27120555 [NOT CITED] [LATEST Version]
  35. Valproate for schizophrenia. PMID: 18646098 [NOT CITED] [LATEST Version]
  36. Valproate for schizophrenia. PMID: 14974054 [NOT CITED] [OLD Version]
1905 Q5643617 Haltlose personality disorder Haltlose personality disorder Stub 3-Mid

Psychiatry

 No matching publication found!
2526 Q721073 delusional disorder Delusional disorder C 3-Mid

Psychiatry
  1. Antipsychotic drug treatment for elderly people with late-onset schizophrenia. PMID: 12804499 [NOT CITED] [LATEST Version]
  2. Asenapine versus placebo for schizophrenia. PMID: 26599405 [NOT CITED] [LATEST Version]
  3. Different communication strategies for disclosing a diagnosis of schizophrenia and related disorders. PMID: 29064090 [NOT CITED] [LATEST Version]
  4. Pimozide for schizophrenia or related psychoses. PMID: 24194433 [NOT CITED] [LATEST Version]
  5. Pimozide for schizophrenia or related psychoses. PMID: 17636692 [NOT CITED] [OLD Version]
  6. Pimozide for schizophrenia or related psychoses. PMID: 10796672 [NOT CITED] [OLD Version]
  7. Pimozide for schizophrenia or related psychoses. PMID: 10908518 [NOT CITED] [OLD Version]
  8. Treatments for delusional disorder. PMID: 25997589 [NOT CITED] [LATEST Version]
4073 Q2300749 separation anxiety disorder Separation anxiety disorder C 4-Low

Psychiatry

 No matching publication found!
301 Q335941 aboulia Aboulia Start 4-Low

Neurology

Psychiatry

 No matching publication found!
500 Q1328833 oppositional defiant disorder Oppositional defiant disorder C 4-Low

Psychiatry
  1. Atypical antipsychotics for disruptive behaviour disorders in children and youths. PMID: 22972123 [NOT CITED] [LATEST Version]
  2. Parent training interventions for Attention Deficit Hyperactivity Disorder (ADHD) in children aged 5 to 18 years. PMID: 22161373 [NOT CITED] [LATEST Version]
2852 Q1779438 piblokto Piblokto C 4-Low

Psychiatry

 No matching publication found!
4417 Q1069110 Cotard delusion Cotard delusion C 4-Low

Psychiatry

 No matching publication found!
963 Q5156653 Complicated grief disorder Complicated grief disorder Start 4-Low

Psychiatry

 No matching publication found!
1043 Q3208285 post-schizophrenic depression Post-schizophrenic depression C 4-Low

Psychiatry

 No matching publication found!
3989 Q2215516 ideas of reference and delusions of reference Ideas of reference and delusions of reference Start 4-Low

Psychiatry

 No matching publication found!
97 Q178059 paraphilia Paraphilia C 4-Low

Psychiatry

 No matching publication found!
252 Q320719 dependent personality disorder Dependent personality disorder Start 4-Low

Psychiatry

 No matching publication found!
1210 Q621053 taijin kyofusho Taijin kyofusho Start 4-Low

Psychiatry

 No matching publication found!
3896 Q2054837 misophonia Misophonia Start 4-Low

Psychiatry

 No matching publication found!
1771 Q3813663 early infantile epileptic encephalopathy 9 Epilepsy-intellectual disability in females C 4-Low

Neurology

Psychiatry
  1. Acupuncture for functional dyspepsia. PMID: 25306866 [NOT CITED] [LATEST Version]
  2. High-intensity versus low-intensity physical activity or exercise in people with hip or knee osteoarthritis. PMID: 26513223 [NOT CITED] [LATEST Version]
  3. Omega-3 fatty acids for bipolar disorder. PMID: 18425912 [NOT CITED] [LATEST Version]
  4. Tirilazad for acute ischaemic stroke. PMID: 11687138 [NOT CITED] [LATEST Version]
1481 Q3065932 cognitive disorder Cognitive disorder Start 4-Low

Psychiatry
  1. Efficacy of nicergoline in dementia and other age associated forms of cognitive impairment. PMID: 11687175 [NOT CITED] [LATEST Version]
  2. Interventions for motor apraxia following stroke. PMID: 18254038 [NOT CITED] [LATEST Version]
1011 Q580754 self-defeating personality disorder Self-defeating personality disorder C 4-Low

Psychiatry

 No matching publication found!
3114 Q7550406 social emotional agnosia Social-emotional agnosia Start 4-Low

Psychiatry

 No matching publication found!